Amedeo Smart

Free Medical Literature Service

 

Amedeo

Contraception and Contraceptive Drugs
  Free Subscription

Articles published in
Contraception
    December 2024
  1. LIU SM, Henkel A, Meza P, Shorter JM, et al
    Comparing transcervical balloon with osmotic dilators for cervical preparation prior to procedural abortion: A noninferiority randomized trial.
    Contraception. 2024;140:110550.
    >> Share

  2. ANGER HA, Raymond EG
    Clinical and service delivery outcomes following medication abortion provided with or without pretreatment ultrasound or pelvic examination: An updated comparative analysis.
    Contraception. 2024;140:110552.
    >> Share

  3. KAPP N, Bawah AA, Agula C, Menzel JL, et al
    Medical abortion in Ghana: A non-randomized, non-inferiority study of access through pharmacies compared with clinics.
    Contraception. 2024;140:110538.
    >> Share

    November 2024
  4. RICKER EA, De Souza MJ, Stone MS, Jackson GS, et al
    Differential bone calcium retention with the use of oral versus vaginal hormonal contraception: A randomized trial using calcium-41 radiotracer().
    Contraception. 2024 Nov 28:110778. doi: 10.1016/j.contraception.2024.110778.
    >> Share

  5. DARNEY BG, Boniface ER, Riosmena F, Fuentes-Rivera E, et al
    Immigrant policy climates and contraceptive use among Mexican origin women in the US: Support for the "spill-over" hypothesis.
    Contraception. 2024 Nov 21:110773. doi: 10.1016/j.contraception.2024.110773.
    >> Share

  6. QUINONES N, Fuentes L, Hassan A, Hing AK, et al
    Corrigendum to Society of Family Planning Research Practice Support: Strategies and considerations for addressing race and racism in quantitative family planning studies [Contraception vol 139 (2024) 110534].
    Contraception. 2024 Nov 9:110736. doi: 10.1016/j.contraception.2024.110736.
    >> Share

  7. PARKER AB, Morse JE, Bryant AG
    Permanent Contraception in the childfree population: an exploratory study.
    Contraception. 2024 Nov 8:110746. doi: 10.1016/j.contraception.2024.110746.
    >> Share

  8. PAGE ST
    Synthetic Androgens for Male Contraception.
    Contraception. 2024 Nov 6:110735. doi: 10.1016/j.contraception.2024.110735.
    >> Share

  9. BERG KA, Gunzler DD, Miller E, Boozer M, et al
    Modeling the impact of decreasing waiting period length for Medicaid sterilization: A multi-site cohort study.
    Contraception. 2024;139:110531.
    >> Share

    October 2024
  10. BITZER J
    Male Contraception - part of gender medicine and reproductive right of men.
    Contraception. 2024 Oct 30:110734. doi: 10.1016/j.contraception.2024.110734.
    >> Share

  11. KING T, Caliendo E, Scott E, Diaz GL, et al
    Suspected Hepatotoxicity from Etonogestrel Contraceptive Implant: A Rare Case Report.
    Contraception. 2024 Oct 17:110728. doi: 10.1016/j.contraception.2024.110728.
    >> Share

  12. GALLO MF, Schumacher FL, Lawley M, Keim SA, et al
    Potential effect of immediate postpartum use of injectable contraception on lactogenesis.
    Contraception. 2024 Oct 16:110726. doi: 10.1016/j.contraception.2024.110726.
    >> Share

  13. ZWAYNE N, Ebersole A, Morse J, Lyman E, et al
    Society of Family Planning Committee statement: Contraception and body weight.
    Contraception. 2024 Oct 11:110725. doi: 10.1016/j.contraception.2024.110725.
    >> Share

  14. AXINN WG, West BT, Schroeder HM, Lindberg LD, et al
    Pandemic changes in U.S. contraceptive use: National survey estimates reveal significant differences by demographic subgroups.
    Contraception. 2024 Oct 3:110723. doi: 10.1016/j.contraception.2024.110723.
    >> Share

  15. LACY YOUNG M, Mastronardi A, Shelton Z, Maples JM, et al
    Tennessee Medicaid patient immediate postpartum long-acting reversible contraception utilization.
    Contraception. 2024 Oct 1:110721. doi: 10.1016/j.contraception.2024.110721.
    >> Share

    September 2024
  16. OBEDIN-MALIVER J, Snow A, Ragosta S, Fix L, et al
    Contraceptive use among transgender men and gender diverse individuals in the United States: reasons for use, non-use, and methods used for pregnancy prevention.
    Contraception. 2024 Sep 26:110719. doi: 10.1016/j.contraception.2024.110719.
    >> Share

  17. MANN ES, Hartheimer J, Bullington BW, Thornton MJ, et al
    Beyond stigma: Clinician bias in contraceptive counseling to sexual and gender minority youth.
    Contraception. 2024 Sep 25:110718. doi: 10.1016/j.contraception.2024.110718.
    >> Share

  18. CARMODY MD, Tsevat D, Yates L, Stuart G, et al
    The Association between Socio-Economic Deprivation and Receipt of Long-Acting Reversible Contraception at a Single Clinic Visit.
    Contraception. 2024 Sep 13:110705. doi: 10.1016/j.contraception.2024.110705.
    >> Share

  19. ALLISON BA, Bullington BW, Makhijani SA, Arora KS, et al
    Exploring Primary Care Physician Biases in Adolescent Contraceptive Counseling.
    Contraception. 2024 Sep 13:110706. doi: 10.1016/j.contraception.2024.110706.
    >> Share

  20. BROWN JA, Ly SH, Thompson JA, Ponizini MD, et al
    Contraceptive Counseling Training Experiences and Behaviors Among Obstetrics and Gynecology Residents in California and Florida.
    Contraception. 2024 Sep 5:110702. doi: 10.1016/j.contraception.2024.110702.
    >> Share

  21. CARTER G, Pangasa M, Sexsmith CD, Elliott S, et al
    Selection of LARC methods by emergency contraception clients: A prospective observational study.
    Contraception. 2024 Sep 4:110701. doi: 10.1016/j.contraception.2024.110701.
    >> Share

  22. FREEMAN E, Paul R, Dorsey M, Rivera AN, et al
    Demographic differences between patients selecting video or telephone for contraceptive counseling via telehealth.
    Contraception. 2024 Sep 2:110699. doi: 10.1016/j.contraception.2024.110699.
    >> Share

  23. BESHAR I, Miller HE, Kruger S, Henkel A, et al
    Mifepristone and misoprostol in California pharmacies after modifications to the Risk Evaluation and Mitigation Strategy Program.
    Contraception. 2024;137:110506.
    >> Share

  24. MNUK R, Schrote K, Garg B, Doshi U, et al
    Availability of mifepristone and misoprostol in Oregon pharmacies: A comparison by rural and urban status.
    Contraception. 2024;137:110491.
    >> Share

  25. DE OLIVEIRA BR, Alsamman S, Pai M, Mody SK, et al
    "My IUD is expiring": A national U.S. mystery client study regarding use of the LNG 52-mg IUD for pregnancy prevention beyond 5 years after multiple FDA extensions.
    Contraception. 2024;137:110483.
    >> Share

    August 2024
  26. SITRUK-WARE R, Sailer J, Serfaty D, Anderson R, et al
    A new vision for male contraception research and development.
    Contraception. 2024 Aug 28:110695. doi: 10.1016/j.contraception.2024.110695.
    >> Share

  27. PATEL J, Nelson AL, Nguyen BT
    Low to non-existent sperm content of pre-ejaculate in perfect-use contraceptive withdrawal, a pilot study.
    Contraception. 2024 Aug 7:110555. doi: 10.1016/j.contraception.2024.110555.
    >> Share

  28. TEIXEIRA DA SILVA JA
    Bibliometric assessment of three retracted papers related to the abortion pill (mifepristone).
    Contraception. 2024;136:110477.
    >> Share

  29. BLECK RR, Danvers AA, Nimbvikar A, Gurney EP, et al
    Medical management of early pregnancy loss with mifepristone and misoprostol in emergency departments compared to a Complex Family Planning office: Implementation of a COVID-19 institutional policy change.
    Contraception. 2024;136:110467.
    >> Share

    July 2024
  30. LAZORWITZ A, Sheeder J, Teal S
    The influence of lifestyle factors on serum etonogestrel concentrations among contraceptive implant users.
    Contraception. 2024 Jul 11:110539. doi: 10.1016/j.contraception.2024.110539.
    >> Share

  31. CARROLL AL, Strauss AM, Philipps NM, Kaczmarczik KD, et al
    Efficacy of medication abortion with concurrent initiation of progestin contraceptives: a retrospective cohort study.
    Contraception. 2024 Jul 8:110536. doi: 10.1016/j.contraception.2024.110536.
    >> Share

  32. OLIVEIRA JA, Eskandar K, Chagas J, do Nascimento LLO, et al
    Heavy menstrual bleeding in women with inherited bleeding disorders in use of LNG-IUS: A systematic review and single-arm meta-analysis.
    Contraception. 2024;135:110450.
    >> Share

  33. DEHLENDORF C, Perry JC, Borrero S, Callegari L, et al
    Meeting people's pregnancy prevention needs: Let's not force people to state an "Intention".
    Contraception. 2024;135:110400.
    >> Share

    June 2024
  34. VISWANATHAN AV, Bullington BW, Berg KA, Miller ES, et al
    Ongoing contraceptive goals of patients who did not achieve desired postpartum permanent contraception prior to hospital discharge.
    Contraception. 2024 Jun 28:110533. doi: 10.1016/j.contraception.2024.110533.
    >> Share

  35. CAIRNS-SMITH S, Jaffe HK, Joseph Speidel J
    Contraceptive technology is failing to meet the needs of people in the U.S. because of under-investment in new methods.
    Contraception. 2024 Jun 17:110518. doi: 10.1016/j.contraception.2024.110518.
    >> Share

  36. JUM'AH D, Abu-Farha R, Alzoubi KH, Binsaleh AY, et al
    Evaluating Community Pharmacists Awareness, Perception and Roles in Providing Emergency Contraceptives in Jordan.
    Contraception. 2024 Jun 13:110515. doi: 10.1016/j.contraception.2024.110515.
    >> Share

  37. RODRIGUEZ MI, Meath THA, Watson K, Daly A, et al
    Decomposition analysis of racial and ethnic differences in receipt of immediate postpartum, long-acting, reversible and permanent contraception.
    Contraception. 2024 Jun 7:110512. doi: 10.1016/j.contraception.2024.110512.
    >> Share

  38. UPADHYAY UD, Adkins CE
    Deception by obfuscation: Studnicki et al.'s retracted longitudinal cohort study of emergency room utilization following abortion.
    Contraception. 2024;134:110417.
    >> Share

  39. DUTTON C, Mody SK, Nippita S, Dodge LE, et al
    Depot medroxyprogesterone acetate concentrations in patients with and without the use of antiseizure medications.
    Contraception. 2024;134:110418.
    >> Share

  40. SHARMA K, Cox S, Romero L, Ekwueme D, et al
    State Variations in Insertion of Long-Acting Reversible Contraception During Delivery Hospitalization.
    Contraception. 2024 Jun 1:110509. doi: 10.1016/j.contraception.2024.110509.
    >> Share

    May 2024
  41. HAGEY JM, Drury KE, Kaplan S, Davidson BA, et al
    Contraceptive Use Following Gestational Trophoblastic Disease: A Systematic Review.
    Contraception. 2024 May 17:110488. doi: 10.1016/j.contraception.2024.110488.
    >> Share

  42. TODD CS, Lorenzetti L, Mussa A, Ridgeway K, et al
    Drug-Drug Interactions between Antiretrovirals and Hormonal Contraception: An Updated Systematic Review.
    Contraception. 2024 May 16:110490. doi: 10.1016/j.contraception.2024.110490.
    >> Share

  43. MAHR NM, Brown JE
    Contraception and Abortion Attitudes Among Military Medical Students: An Exploratory Study.
    Contraception. 2024 May 15:110489. doi: 10.1016/j.contraception.2024.110489.
    >> Share

  44. KENDALL PD, Bresnitz W, Huang J, Sheeder J, et al
    A retrospective analysis of factors associated with deep contraceptive implant removals compared to superficial removals.
    Contraception. 2024 May 14:110486. doi: 10.1016/j.contraception.2024.110486.
    >> Share

  45. HEGGIE C, Tong L, Heran A, Bhambhani I, et al
    The role of doulas and community birth workers in abortion and contraception care: An international scoping review.
    Contraception. 2024 May 9:110482. doi: 10.1016/j.contraception.2024.110482.
    >> Share

  46. STEVENSON TB, Thapaliya K, Moore V, Mazza D, et al
    Accessibility of oral emergency contraceptives in Australian community pharmacies.
    Contraception. 2024 May 4:110480. doi: 10.1016/j.contraception.2024.110480.
    >> Share

  47. SIMS JC, Harris JN, Katzman CL, Wong C, et al
    Confidence in adolescent contraceptive counseling among residents and fellows training at the University of Texas Southwestern in Dallas, Texas.
    Contraception. 2024 May 3:110478. doi: 10.1016/j.contraception.2024.110478.
    >> Share

  48. LAURORA I, Henrie B, Guillard H, Bradford R, et al
    Evaluation of adherence to a daily progestin-only pill in a simulated over-the-counter setting.
    Contraception. 2024;133:110388.
    >> Share

  49. LA SAPONARA V, Wan S, Nagarkar B, Zwain F, et al
    Understanding the mechanical behavior of intrauterine devices during simulated removal.
    Contraception. 2024;133:110399.
    >> Share

  50. DAVIS S, Parthun K, Friend DR
    A nine-month repeat-dose intravaginal ring (Ovaprene) irritation study in sheep.
    Contraception. 2024;133:110387.
    >> Share

  51. PERELLO-CAPO J, Estadella-Tarriel J, Gich-Saladich I, Bailon-Queiruga M, et al
    Health-related quality of life and satisfaction associated with 3-year use of a levonorgestrel 13.5 mg intrauterine device vs Nova T copper 380 mm(2) intrauterine device: Results of a phase 4 randomized controlled trial.
    Contraception. 2024;133:110367.
    >> Share

    April 2024
  52. JENSEN JT, Edelman A, Westhoff CL, Schreiber CA, et al
    Use of serum evaluation of contraceptive and ovarian hormones to assess reduced risk of pregnancy among women presenting for emergency contraception in a multicenter clinical trial.
    Contraception. 2024 Apr 24:110475. doi: 10.1016/j.contraception.2024.110475.
    >> Share

  53. EDELMAN A, Jensen JT, Brown J, Thomas M, et al
    Emergency contraception for individuals weighing 80kg or greater: a randomized trial of 30 mg ulipristal acetate and 1.5 mg or 3.0 mg levonorgestrel.
    Contraception. 2024 Apr 23:110474. doi: 10.1016/j.contraception.2024.110474.
    >> Share

  54. MITCHELL JA, Yao M, Maeda R, Lappen JR, et al
    Permanent and Long-Acting Reversible Contraception volumes at a multi-hospital system in Ohio before and after Dobbs.
    Contraception. 2024 Apr 20:110471. doi: 10.1016/j.contraception.2024.110471.
    >> Share

  55. BRANDER C, Risher K, Odwe G, Wado YD, et al
    Individual, partner, and community variables associated with method-specific contraceptive beliefs in urban and rural Kenya.
    Contraception. 2024 Apr 17:110470. doi: 10.1016/j.contraception.2024.110470.
    >> Share

  56. CONGDON JL, Vittinghoff E, Dehlendorf C
    Comparison of a Person-Centered Pregnancy Prevention Question and One Key Question(R) to Assess Postpartum Contraceptive Needs.
    Contraception. 2024 Apr 16:110465. doi: 10.1016/j.contraception.2024.110465.
    >> Share

  57. MASTERS GA, Julce C, Carroll S, Person SD, et al
    Association of Perinatal Depression and Postpartum Contraception Intent, Choice, and Actual Use.
    Contraception. 2024 Apr 5:110447. doi: 10.1016/j.contraception.2024.110447.
    >> Share

  58. LAZARIS E, Sanders JN, Carter G, Olsen J, et al
    Contraceptive uptake among gender-expansive individuals in the HER Salt Lake Contraceptive Initiative.
    Contraception. 2024 Apr 5:110446. doi: 10.1016/j.contraception.2024.110446.
    >> Share

  59. HAEDER SF, Marthey D, Skinner D
    US public opinion about reproductive health care in school-based health centers.
    Contraception. 2024;132:110374.
    >> Share

  60. LAMBERT SJ, Lunde B, Porsch L, Stoffels G, et al
    Adjuvant misoprostol or mifepristone for cervical preparation with osmotic dilators before dilation and evacuation.
    Contraception. 2024;132:110364.
    >> Share

  61. FREE LL, Brown BP, Matteson KA, Cronin B, et al
    Longitudinal impact of a residency-based postplacental levonorgestrel intrauterine device insertion program: Expulsion rates in years 1, 2, and 3.
    Contraception. 2024;132:110362.
    >> Share

  62. SIUM AF, Teklu H, Reeves M, Tolu LB, et al
    One-day versus two-day mifepristone-misoprostol interval prior to initiation of misoprostol during late second trimester medication abortion: A cohort study.
    Contraception. 2024;132:110356.
    >> Share

    March 2024
  63. LANDS M, Dyer RL, Seymour JW
    Corrigendum to: "Sampling strategies among studies of barriers to abortion in the United States: A scoping review of abortion access research'' [Contraception 2024; 131:110342].
    Contraception. 2024 Mar 29:110435. doi: 10.1016/j.contraception.2024.110435.
    >> Share

  64. NGUYEN BT
    The Demand for Male Contraception: estimating the potential market for users of novel male contraceptive methods using United States National Survey of Family Growth data.
    Contraception. 2024 Mar 28:110438. doi: 10.1016/j.contraception.2024.110438.
    >> Share

  65. MONACO AE, Westhoff CL
    Evaluating virtual visits for contraceptive counseling: an exploratory study using the Person-Centered Contraceptive Counseling (PCCC) scale, a patient-reported outcome measure.
    Contraception. 2024 Mar 27:110443. doi: 10.1016/j.contraception.2024.110443.
    >> Share

  66. CLURE C, Sheeder J, Lazorwitz A
    Pilot study of a novel, alternative subdermal scapular insertion site for the etonogestrel contraceptive implant.
    Contraception. 2024 Mar 27:110442. doi: 10.1016/j.contraception.2024.110442.
    >> Share

  67. STEWART A, Lisa Romero, Kortsmit K, Hurst S, et al
    Long-Acting Reversible Contraception Use and Unmet Desire among Patients After the Zika Contraception Access Network Program in Puerto Rico.
    Contraception. 2024 Mar 27:110441. doi: 10.1016/j.contraception.2024.110441.
    >> Share

  68. MAUCK C, Thurman A, Jensen JT, Schreiber CA, et al
    Safety Testing of Ovaprene: an Investigational Non-Hormonal Monthly Vaginal Contraceptive.
    Contraception. 2024 Mar 27:110440. doi: 10.1016/j.contraception.2024.110440.
    >> Share

  69. HUMPHREYS A, Stevenson AJ, Yeatman S
    Changes in Contraceptive Method Mix Following the Colorado Family Planning Initiative.
    Contraception. 2024 Mar 21:110422. doi: 10.1016/j.contraception.2024.110422.
    >> Share

  70. YARGER J, Hopkins K, Elmes S, Rossetto I, et al
    Use of telemedicine to obtain contraception among young adults: Inequities by health insurance.
    Contraception. 2024 Mar 9:110419. doi: 10.1016/j.contraception.2024.110419.
    >> Share

  71. WAGNER B, Cleland K
    Increases in Retail Sales of Over-the-counter Levonorgestrel Emergency Contraception in the United States, 2016-2022.
    Contraception. 2024 Mar 8:110420. doi: 10.1016/j.contraception.2024.110420.
    >> Share

  72. COMFORT AB, Alvarez A, Goodman S, Upadhyay U, et al
    Provision of DMPA-SC for self-administration in different practice settings during the COVID-19 pandemic: Data from providers across the United States.
    Contraception. 2024;131:110360.
    >> Share

  73. SANDOVAL S, Rafie S, Kully G, Mody S, et al
    Pharmacist provision of medication abortion: A pilot study.
    Contraception. 2024;131:110346.
    >> Share

  74. JOHNSON DM, Ramaswamy S, Gomperts R
    Experiences with misoprostol-only used for self-managed abortion and acquired from an online or retail pharmacy in the United States.
    Contraception. 2024;131:110345.
    >> Share

  75. BHARADWA S, Fulcher I, Fortin J, Pocius KD, et al
    hCG trends after mifepristone and misoprostol for undesired pregnancy of unknown location.
    Contraception. 2024;131:110343.
    >> Share

  76. RAYMOND EG, Frye LJ, Tocce K, Gingras S, et al
    Evaluation of a "smart" screening tool for asynchronous assessment of medication abortion eligibility: A pilot study.
    Contraception. 2024;131:110340.
    >> Share

    February 2024
  77. MEURICE ME, Mody SK, Nodora J, Marengo A, et al
    Social determinants of choosing telemedicine for contraceptive care: a retrospective cohort study.
    Contraception. 2024 Feb 29:110414. doi: 10.1016/j.contraception.2024.110414.
    >> Share

  78. TSEVAT D, Mercier R, Bernheimer C, Lin S, et al
    Amenorrhea in Adolescents Using the Etonogestrel Contraceptive Implant.
    Contraception. 2024 Feb 22:110413. doi: 10.1016/j.contraception.2024.110413.
    >> Share

  79. SOBER S, Bradford R, Henrie B, Pradeau S, et al
    Evaluation of consumer self-selection of a proposed over-the-counter, progestin-only daily oral contraceptive.
    Contraception. 2024 Feb 21:110401. doi: 10.1016/j.contraception.2024.110401.
    >> Share

  80. SAKTHIVEL M, Wolff H, Monast K, McHugh A, et al
    Mifepristone implementation in primary care: Clinician and staff insights from a pilot learning collaborative.
    Contraception. 2024;130:110280.
    >> Share

    January 2024
  81. PAIK J, Haenisch M, Kim A, Snyder JM, et al
    Corrigendum to: "Return to fertility, toxicology, and transgenerational impact of treatment with WIN 18,446, a potential male contraceptive, in mice" [Contraception. 129 (2024) 110306].
    Contraception. 2024 Jan 22:110371. doi: 10.1016/j.contraception.2024.110371.
    >> Share

  82. BOEHNKE T, Franke C, Bauerfeind A, Heinemann K, et al
    Systematic analysis of combined oral contraceptive prescription patterns in psychotropic drug users across 12 European countries.
    Contraception. 2024 Jan 20:110375. doi: 10.1016/j.contraception.2024.110375.
    >> Share

  83. FATIMA LL, Alonso Llamazares MJ, Mausbach Reisen H, Parra Ribes I, et al
    Impact of the hands-on Clinical Training Program (CTP) for subdermic implant on contraceptive counselling and users' choice in Spain: A six months follow up study.
    Contraception. 2024 Jan 16:110372. doi: 10.1016/j.contraception.2024.110372.
    >> Share

  84. MAUCK C, Thurman A, Jensen JT, Schreiber CA, et al
    Successful Postcoital Testing of Ovaprene: an Investigational Non-Hormonal Monthly Vaginal Contraceptive.
    Contraception. 2024 Jan 15:110373. doi: 10.1016/j.contraception.2024.110373.
    >> Share

  85. GAWRON LM, Kaiser JE, Gero A, Sanders JN, et al
    Pharmacodynamic evaluation of the etonogestrel contraceptive implant initiated midcycle with and without ulipristal acetate: an exploratory study.
    Contraception. 2024 Jan 15:110370. doi: 10.1016/j.contraception.2024.110370.
    >> Share

  86. CARRANCO S, Bohac S, Casey S, Sangi-Haghpeykar H, et al
    A Survey Of Contraceptive Method Use Among Patients With Delayed Permanent Contraception Due To The COVID-19 Pandemic.
    Contraception. 2024 Jan 13:110369. doi: 10.1016/j.contraception.2024.110369.
    >> Share

  87. HALE N, Dehlendorf C, Smith MG, Stapleton J, et al
    Contraceptive Counseling, Method Satisfaction, and Planned Method Continuation among Women in the U.S. Southeast.
    Contraception. 2024 Jan 10:110365. doi: 10.1016/j.contraception.2024.110365.
    >> Share

  88. LAPORTE M, Marcelino AC, Pereira PDC, Espejo-Arce X, et al
    Uptake, discontinuation, and continuation rate of long-acting contraceptive methods (LARC) when offered at no cost in Campinas, Brazil.
    Contraception. 2024 Jan 7:110363. doi: 10.1016/j.contraception.2024.110363.
    >> Share

  89. SOKOL NA, Sawadogo N, Bullington BW, Tumlinson K, et al
    Perceptions of access to long-acting reversible contraception removal among women in Burkina Faso.
    Contraception. 2024;129:110302.
    >> Share

  90. GEDESTAD I, Munnangi M, Chamberlain A, Shabaik S, et al
    Five years later: Can women in Los Angeles County, California, get adequate pill supplies?
    Contraception. 2024;129:110294.
    >> Share

    December 2023
  91. YI H, Stamm CA, Wright G, Mondie WS, et al
    Emergency contraception in a historic southern city: mystery caller study in Birmingham, Alabama.
    Contraception. 2023 Dec 29:110361. doi: 10.1016/j.contraception.2023.110361.
    >> Share

  92. BORGES ALV, Lay AAR, Duarte LS, Chofakian CBDN, et al
    Changes in contraceptive use during the second COVID-19 lockdown in Brazil: a web-based survey.
    Contraception. 2023 Dec 28:110359. doi: 10.1016/j.contraception.2023.110359.
    >> Share

  93. SINTHUCHAI N, Tapanwong N, Apirakviriya C, Pohthipornthawat N, et al
    The effect of a single-dose of a combination injectable contraceptive for treatment of bothersome uterine bleeding in contraceptive implant(s) users; a randomized double-blind placebo-controlled trial.
    Contraception. 2023 Dec 14:110354. doi: 10.1016/j.contraception.2023.110354.
    >> Share

  94. DOTY N, Beckley E, Garg B, Maristany S, et al
    Changes in hair cortisol concentration in intrauterine device initiators: A prospective cohort study.
    Contraception. 2023;128:110142.
    >> Share

  95. CHATILLON A, Vizcarra E, Kumar B, Dickman SL, et al
    Access to care following Planned Parenthood's termination from Texas' Medicaid network: A qualitative study.
    Contraception. 2023;128:110141.
    >> Share

  96. SPIELVOGEL R, Stephens RB, Clark R, Guillen M, et al
    Providing family planning counseling services for women with chronic medical conditions in an inpatient setting: A randomized feasibility trial.
    Contraception. 2023;128:110133.
    >> Share

    November 2023
  97. STOWERS P, Heck R, Csiszar K, Kaneshiro B, et al
    Corrigendum to "Just world beliefs and community-level abortion stigma: An exploratory survey" [Contraception 2023;122:109979].
    Contraception. 2023 Nov 27:110341. doi: 10.1016/j.contraception.2023.110341.
    >> Share

  98. GAWRON LM, Sexsmith CD, Carter G, Kaiser JE, et al
    Efficacy of oral levonorgestrel emergency contraception with same day etonogestrel contraceptive implant: A prospective observational study.
    Contraception. 2023 Nov 24:110344. doi: 10.1016/j.contraception.2023.110344.
    >> Share

  99. SZNAJDER K, Thaler K, Perin J, Burke AE, et al
    Development and evaluation of measures to assess self-determination in peripartum contraceptive decision-making.
    Contraception. 2023 Nov 16:110329. doi: 10.1016/j.contraception.2023.110329.
    >> Share

  100. PERELLO-CAPO J, Estadella-Tarriel J, Gich-Saladich I, Bailon-Queiruga M, et al
    Bleeding profile and safety of a levonorgestrel 13.5 mg intrauterine device versus Nova T copper 380 mm(2) intrauterine device: Results of a 3-year, single-center, randomized phase 4 study.
    Contraception. 2023;127:110127.
    >> Share

  101. RAYMOND EG, Weaver MA, Shochet T
    Effectiveness and safety of misoprostol-only for first-trimester medication abortion: An updated systematic review and meta-analysis.
    Contraception. 2023;127:110132.
    >> Share

    October 2023
  102. JONAS K, Bergh K, Duby Z, Mangoale K, et al
    Using prevention cascades to investigate coverage of contraception services among young women enrolled in a large-scale combination HIV prevention programme in South Africa.
    Contraception. 2023 Oct 18:110307. doi: 10.1016/j.contraception.2023.110307.
    >> Share

  103. STANCZYK FZ, Winer SA, Foidart JM, Archer DF, et al
    Comparison of Estrogenic Components Used for Hormonal Contraception.
    Contraception. 2023 Oct 18:110310. doi: 10.1016/j.contraception.2023.110310.
    >> Share

  104. LINDER M, Schoendorf J, Pisa F, Schulze-Rath R, et al
    Characteristics and hormonal contraception use patterns of levonorgestrel 13.5 mg intrauterine device users in Sweden 2014-2016.
    Contraception. 2023 Oct 14:110309. doi: 10.1016/j.contraception.2023.110309.
    >> Share

  105. PAIK J, Haenisch M, Kim A, Snyder JM, et al
    Return to Fertility, Toxicology, and Transgenerational Impact of Treatment with WIN 18,446, a Potential Male Contraceptive, in Mice.
    Contraception. 2023 Oct 7:110306. doi: 10.1016/j.contraception.2023.110306.
    >> Share

  106. WINGO E, Dehlendorf C
    Lack of pregnancy intention or interest in pregnancy prevention now? How best to screen for desire for contraceptive care.
    Contraception. 2023 Oct 6:110303. doi: 10.1016/j.contraception.2023.110303.
    >> Share

  107. WOLFF H, McHugh A, Qadir S, Lassar M, et al
    Reproductive care in community health centers: Multi-method evaluation of the Illinois Contraceptive Access Now (ICAN!) demonstration program.
    Contraception. 2023 Oct 6:110305. doi: 10.1016/j.contraception.2023.110305.
    >> Share

  108. SHIM JY, Ryan ME, Milliren CE, Maslyanskaya S, et al
    Continuation Rates of Hormonal Intrauterine Devices in Adolescents and Young Adults when placed for Contraceptive and Non-Contraceptive Indications.
    Contraception. 2023 Oct 6:110304. doi: 10.1016/j.contraception.2023.110304.
    >> Share

  109. COSTANZO MA, Magnuson KA, Gennetian LA, Halpern-Meekin S, et al
    Contraception Use and Satisfaction Among Mothers with Low-Income: Evidence from the Baby's First Years Study.
    Contraception. 2023 Oct 6:110297. doi: 10.1016/j.contraception.2023.110297.
    >> Share

  110. JANTTI C, Toffol E, Partonen T, Haukka J, et al
    Contraceptive plans and purchase after an induced abortion: a nationwide register study from Finland.
    Contraception. 2023 Oct 5:110299. doi: 10.1016/j.contraception.2023.110299.
    >> Share

  111. DIAMOND B, Sheeder J, Lazorwitz A
    An exploratory study on the possible association of serum etonogestrel concentrations with mood concerns and symptoms among contraceptive implant users.
    Contraception. 2023 Oct 4:110298. doi: 10.1016/j.contraception.2023.110298.
    >> Share

  112. STODDARD RE, Pelletier A, Sundquist EN, Haas-Kogan ME, et al
    Popular Contraception Videos on TikTok: An Assessment of Content Topics.
    Contraception. 2023 Oct 4:110300. doi: 10.1016/j.contraception.2023.110300.
    >> Share

  113. BAKER CC, Wu BT, Han G, Flynn AN, et al
    Early pregnancy loss medical management in clinical practice.
    Contraception. 2023;126:110134.
    >> Share

  114. JUAREZ-CHAVEZ E, Villalobos Ruiz JH, Carrasco Navarro RM, Guerrero Vasquez R, et al
    Exploring the prevalence of abortion and its characteristics in Peru.
    Contraception. 2023;126:110115.
    >> Share

  115. NEILL S, Hoe E, Fortin J, Goldberg AB, et al
    Management of early pregnancy loss among obstetrician-gynecologists in Massachusetts and barriers to mifepristone use.
    Contraception. 2023;126:110108.
    >> Share

  116. RAYMOND EG, Weaver MA, Shochet T, Grant M, et al
    Clinical outcomes of medication abortion using misoprostol-only: A retrospective chart review at an abortion provider organization in the United States.
    Contraception. 2023;126:110109.
    >> Share

    September 2023
  117. JONAS K, Lombard C, Chirinda W, Govindasamy D, et al
    Corrigendum to "Participation in an HIV prevention intervention and access to and use of contraceptives among young women: A cross-sectional analysis in six South African districts" [Contraception 116 (2022) 51-58].
    Contraception. 2023 Sep 22:110281. doi: 10.1016/j.contraception.2023.110281.
    >> Share

  118. ROBERTS CM, Smalley JM, Adelman WP, Weir LF, et al
    Brief Report: Influence of mandatory contraceptive education emphasizing long-acting reversible methods on continuation rates among military recruits.
    Contraception. 2023 Sep 20:110295. doi: 10.1016/j.contraception.2023.110295.
    >> Share

  119. GAGE AJ, Akilimali PZ, Wood FE, Gay R, et al
    Evaluation of the effect of the Momentum project on family planning outcomes among first-time mothers aged 15-24 years in Kinshasa, DRC.
    Contraception. 2023;125:110088.
    >> Share

  120. DE LOTT LB, Moniz MH, Niziol LM, Khanna S, et al
    Levonorgestrel intrauterine device use and incident idiopathic intracranial hypertension among commercially insured women.
    Contraception. 2023;125:110089.
    >> Share

  121. SIUM AF, Shimeles T, Gudu W
    The effect of induced fetal demise on induction to expulsion interval during later medication abortion: A retrospective cohort.
    Contraception. 2023;125:110092.
    >> Share

  122. DICKINSON JE, Doherty DA
    Maternal complications associated with second trimester medical abortion using mifepristone priming and subsequent misoprostol.
    Contraception. 2023;125:110080.
    >> Share

    August 2023
  123. JONES A, Whitesell C, Tadikonda A, Perry MF, et al
    "I feel like it gives me what I need to know": A qualitative study on adolescent perceptions of two contraceptive decision aids.
    Contraception. 2023 Aug 31:110277. doi: 10.1016/j.contraception.2023.110277.
    >> Share

  124. XUAN NGUYEN TT, Quynh Nguyen TT, Huong Le L, Dinh DX, et al
    Knowledge, attitudes, and practices towards emergency contraceptive pills among community pharmacists and pharmacy customers: a cross-sectional study in urban Vietnam.
    Contraception. 2023 Aug 30:110275. doi: 10.1016/j.contraception.2023.110275.
    >> Share

  125. THOMAS K, Malhotra T, Ngendahimana D, Gibson KS, et al
    Postpartum contraceptive choice and fulfillment in patients with opioid use disorder.
    Contraception. 2023 Aug 24:110267. doi: 10.1016/j.contraception.2023.110267.
    >> Share

  126. MAUCK CK, Dart C, Thurman A, Creinin MD, et al
    Contraceptive efficacy should primarily be measured using life table pregnancy rates.
    Contraception. 2023 Aug 8:110140. doi: 10.1016/j.contraception.2023.110140.
    >> Share

  127. QASBA NT, Wallace KF, Yu V, Capoccia KL, et al
    Online survey of consumer awareness and perceptions of a Massachusetts law for 12-month-supply of contraception.
    Contraception. 2023 Aug 4:110138. doi: 10.1016/j.contraception.2023.110138.
    >> Share

  128. CREININ MD, Angulo A, Colli E, Archer DF, et al
    The efficacy, safety and tolerability of an estrogen-free oral contraceptive drospirenone 4 mg (24/4-day regimen) in obese users.
    Contraception. 2023 Aug 4:110136. doi: 10.1016/j.contraception.2023.110136.
    >> Share

  129. ANGER HA, Raymond EG
    Implications of using home urine pregnancy tests versus facility-based tests for assessment of outcome following medication abortion provided via telemedicine.
    Contraception. 2023;124:110055.
    >> Share

    July 2023
  130. ABERNATHEY L, Ryan ME, Golub S, Ahrens K, et al
    Long-acting Reversible Contraception in Gender-Diverse Adolescents and Young Adults: Outcomes from a Multisite Collaborative.
    Contraception. 2023 Jul 28:110131. doi: 10.1016/j.contraception.2023.110131.
    >> Share

  131. JENSEN JT, Waites BT, Boniface ER, McCrimmon S, et al
    Development and validation of an expanded panel of progestins using liquid chromatography-tandem triple quadrupole mass spectrometry (LC-MS/MS) to monitor protocol compliance in hormonal contraceptive pharmacokinetic/pharmacodynamic studies.
    Contraception. 2023 Jul 25:110130. doi: 10.1016/j.contraception.2023.110130.
    >> Share

  132. FREEMAN E, Paul R, Dorsey M, Madden T, et al
    Comparison of interpersonal quality of contraceptive counseling delivered via telehealth versus in-person.
    Contraception. 2023 Jul 25:110129. doi: 10.1016/j.contraception.2023.110129.
    >> Share

  133. RUELLE Y, Haghighi S, Guillot O
    Effects of a short training workshop on the insertion/removal of intrauterine devices and contraceptive implants by general practice residents and their supervisors.
    Contraception. 2023 Jul 17:110117. doi: 10.1016/j.contraception.2023.110117.
    >> Share

  134. GUTMAN S, Connor H, Mumford SL, Gilmore E, et al
    Feasibility and acceptability of virtual group contraceptive counseling prior to abortion care.
    Contraception. 2023 Jul 17:110114. doi: 10.1016/j.contraception.2023.110114.
    >> Share

  135. ROSENBERG JD, Raymond E, Shochet T
    Corrigendum to "An examination of loss to follow-up and potential bias in outcome ascertainment in a study of direct-to-patient telemedicine abortion in the United States" Contraception, Volume 122, 109996 (June 2023).
    Contraception. 2023 Jul 5:110098. doi: 10.1016/j.contraception.2023.110098.
    >> Share

  136. RODRIGUEZ MI, Acevedo AM, Renfro S, Tasset J, et al
    Association of intrapartum severe maternal morbidity with receipt of postpartum contraception among Medicaid recipients.
    Contraception. 2023 Jul 4:110110. doi: 10.1016/j.contraception.2023.110110.
    >> Share

  137. FIASTRO AE, Young E, Jacob-Files E, Ruben MR, et al
    Advance provision of medication for induced abortion: A qualitative study of patient perspectives.
    Contraception. 2023;123:110050.
    >> Share

  138. DICENZO N, Shah N, Glassman D, Singla A, et al
    Active COVID-19 infection as a barrier to postpartum tubal ligation.
    Contraception. 2023;123:110051.
    >> Share

  139. SMITH TJ, Urdanigo TK, Shroff N, Rubin SE, et al
    Patient's experience and satisfaction with self-administered subcutaneous depot medroxyprogesterone acetate use during the first year of COVID-19.
    Contraception. 2023;123:110008.
    >> Share

  140. BOEHNKE T, Eggebrecht L, Viet M, Heinemann K, et al
    How did regional lockdowns during the COVID-19 pandemic affect recruitment into a large multinational cohort study of intrauterine device users?
    Contraception. 2023;123:110003.
    >> Share

  141. YARON M, Legardeur H, Barcellini B, Akhoundova F, et al
    Safety and efficacy of a suction cervical stabilizer for intrauterine contraceptive device insertion: Results from a randomized, controlled study.
    Contraception. 2023;123:110004.
    >> Share

    June 2023
  142. SILEO KM, Muhumuza C, Wanyenze RK, Kershaw TS, et al
    A pilot quasi-experimental controlled trial of a community-based, multi-level family planning intervention for couples in rural Uganda: evidence of feasibility, acceptability, and effect on contraceptive uptake among those with an unmet need for famil
    Contraception. 2023 Jun 22:110096. doi: 10.1016/j.contraception.2023.110096.
    >> Share

  143. BREWER M, Clifton T
    Religious affiliation and women's receipt of person-centered contraceptive care: Findings from the National Survey of Family Growth, 2017-2019.
    Contraception. 2023 Jun 19:110097. doi: 10.1016/j.contraception.2023.110097.
    >> Share

  144. LAZORWITZ A, Sheeder J
    Validation of 24-hour trough concentration as a proxy for intensive pharmacokinetic measurements for a combined oral contraceptive pill containing desogestrel.
    Contraception. 2023 Jun 16:110093. doi: 10.1016/j.contraception.2023.110093.
    >> Share

  145. KUS LH, Paul R, Nigaglioni Rivera A, Zeal C, et al
    Improvement in contraceptive knowledge after using an online educational resource.
    Contraception. 2023 Jun 16:110095. doi: 10.1016/j.contraception.2023.110095.
    >> Share

  146. OSTERBUR BADHEY ML, Li S, Alimena S, Johnson NR, et al
    Allergic and infectious complications of Etonogestrel implant placements: A case series.
    Contraception. 2023;122:109994.
    >> Share

  147. ANJOS FCQS, Marcelino AC, Espejo-Arce X, Pereira PDC, et al
    Pain and ease of insertion of three different intrauterine devices in Brazilian adolescents: A participant-blinded randomized trial.
    Contraception. 2023;122:109997.
    >> Share

  148. WOLLUM A, Zuniga C, Blanchard K, Teal S, et al
    A commentary on progestin-only pills and the "three-hour window" guidelines: Timing of ingestion and mechanisms of action.
    Contraception. 2023;122:109978.
    >> Share

  149. CIRRINCIONE LR, Nakalema S, Chappell CA, Byakika-Kibwika P, et al
    Effect of double-dose levonorgestrel subdermal implant in women taking efavirenz-based antiretroviral therapy: The DoubLNG pharmacokinetic study.
    Contraception. 2023;122:109975.
    >> Share

    May 2023
  150. MANG A, Jetelina KK, Mcneely C, Durante JC, et al
    Characteristics of parents who think intrauterine devices or contraceptive implants are "best" for their daughter: An exploratory analysis.
    Contraception. 2023 May 30:110084. doi: 10.1016/j.contraception.2023.110084.
    >> Share

  151. LOH M, Niu L, Arden M, Burk RD, et al
    Long-acting reversible contraception and condom use: A cohort study of female adolescents and young adults in New York City.
    Contraception. 2023 May 30:110081. doi: 10.1016/j.contraception.2023.110081.
    >> Share

  152. SULGER E, Jung C, Nippita S
    Avoiding unintended pregnancy during transition from copper intrauterine device to etonogestrel contraceptive implant: A case report.
    Contraception. 2023 May 29:110085. doi: 10.1016/j.contraception.2023.110085.
    >> Share

  153. SONALKAR S, Kete C, McAllister A, Afreen R, et al
    Perceptions of HIV risk screening strategies among patients seeking abortion, contraception, and pregnancy loss management in the United States.
    Contraception. 2023 May 18:110063. doi: 10.1016/j.contraception.2023.110063.
    >> Share

  154. AMORY JK, Blithe DL, Ware RS, Swerdloff RS, et al
    Design of an International Male Contraceptive Efficacy Trial Using a Self-Administered Daily Transdermal Gel Containing Testosterone and Segesterone Acetate (Nestorone(R)).
    Contraception. 2023 May 18:110064. doi: 10.1016/j.contraception.2023.110064.
    >> Share

  155. SHAW JG, Goldthwaite LM, Maric I, Shaw KA, et al
    Postpartum long-acting reversible contraception among privately insured: national analysis 2007-2016, by term and preterm birth.
    Contraception. 2023 May 18:110065. doi: 10.1016/j.contraception.2023.110065.
    >> Share

  156. FOSTER AM, Darney BG, Nguyen BT, Russo J, et al
    Advancing diversity, equity, inclusion, and anti-racism in Contraception: A statement of commitment from the Editorial Board.
    Contraception. 2023 May 17:110066. doi: 10.1016/j.contraception.2023.110066.
    >> Share

  157. ERMIAS Y, Averbach SH, Dey AK, Gebrehanna E, et al
    The Association Between Quality of Contraceptive Counseling and Selection of Contraceptive Method Post-counseling Among Women in Ethiopia.
    Contraception. 2023 May 11:110060. doi: 10.1016/j.contraception.2023.110060.
    >> Share

  158. RAYMOND EG, Mark A, Grossman D, Beasley A, et al
    Medication abortion with misoprostol-only: A sample protocol.
    Contraception. 2023;121:109998.
    >> Share

  159. KOENIG LR, Raymond EG, Gold M, Boraas CM, et al
    Mailing abortion pills does not delay care: A cohort study comparing mailed to in-person dispensing of abortion medications in the United States.
    Contraception. 2023;121:109962.
    >> Share

    April 2023
  160. RODRIGUEZ MI, Skye M, Schrote K, Linz R, et al
    Contraceptive services in Oregon's state-funded network during the COVID-19 pandemic.
    Contraception. 2023 Apr 21:110054. doi: 10.1016/j.contraception.2023.110054.
    >> Share

  161. JONES EJ, Dehlendorf C, Kriz R, Grzeniewski M, et al
    Using the Person-Centered Contraceptive Counseling (PCCC) Measure for Quality Improvement.
    Contraception. 2023 Apr 12:110040. doi: 10.1016/j.contraception.2023.110040.
    >> Share

  162. SHEA M, Decker E, LeRoy L, Winter M, et al
    Testing the Validity and Reliability of the Person-Centered Contraceptive Care (PCCC) Performance Measure in a Real-World Contraceptive Access Program.
    Contraception. 2023 Apr 6:110039. doi: 10.1016/j.contraception.2023.110039.
    >> Share

  163. PAI M, Rigler N, de Oliveira BR, Mody SK, et al
    "My implant is expiring": A national U.S. mystery shopper study regarding extended use of the contraceptive implant.
    Contraception. 2023 Apr 3:110038. doi: 10.1016/j.contraception.2023.110038.
    >> Share

  164. SHADY NW, Farouk HA, Sallam HF
    A randomized double blinded clinical trial to explore the clinical outcomes of vaginal isonicotinic acid hydrazide (INH) administration six hours prior to T380A intrauterine device insertion in persons delivered only by cesarean delivery. Contraceptio
    Contraception. 2023;120:109973.
    >> Share

  165. QUINN DA, Sileanu FE, Borrero S, Callegari LS, et al
    Reproductive health services: A missed opportunity in VA primary care?
    Contraception. 2023;120:109957.
    >> Share

  166. GILBERT AL, Gelfand D, Fortin J, Roncari D, et al
    At-home urine pregnancy test assessment after mifepristone and misoprostol for undesired pregnancy of unknown location.
    Contraception. 2023;120:109955.
    >> Share

  167. JENSEN JT, Reinecke I, Post TM, Lukkari-Lax E, et al
    Extended use of levonorgestrel-releasing intrauterine system (LNG-IUS) 52 mg: A population pharmacokinetic approach to estimate in vivo levonorgestrel release rates and systemic exposure including comparison with two other LNG-IUSs.
    Contraception. 2023;120:109954.
    >> Share

  168. REED S, Minh TD, Lange JA, Koro C, et al
    Pregnancy and pregnancy outcomes in a prospective cohort study: Final results from the Nexplanon Observational Risk Assessment Study (NORA).
    Contraception. 2023;120:109920.
    >> Share

  169. SHOCHET T, Turok D, Frye LJ, Sexsmith CD, et al
    Single dose letrozole and misoprostol for termination of pregnancy through 63 days' gestation: A pilot study.
    Contraception. 2023;120:109924.
    >> Share

    March 2023
  170. LAZORWITZ A, Sheeder J, Teal S
    The effect of rifampin on serum etonogestrel concentrations and biomarkers of ovulation among contraceptive implant users: a pharmacokinetic and pharmacodynamic study.
    Contraception. 2023 Mar 28:110035. doi: 10.1016/j.contraception.2023.110035.
    >> Share

  171. DEHLENDORF C, Vittinghoff E, Silverstein I, Fox E, et al
    Prioritizing Patient Experience: Validation of the Person-Centered Contraceptive Counseling Measure as a Performance Measure.
    Contraception. 2023 Mar 17:110010. doi: 10.1016/j.contraception.2023.110010.
    >> Share

  172. STUART GS, Yates L, Crump J, Allison BA, et al
    Single-visit insertion of long-acting reversible contraception in a single health system.
    Contraception. 2023 Mar 15:110009. doi: 10.1016/j.contraception.2023.110009.
    >> Share

  173. NGUYEN BT, Jacobsohn TL
    Men's willingness to use novel male contraception is linked to gender-equitable attitudes: results from an exploratory online survey.
    Contraception. 2023 Mar 14:110001. doi: 10.1016/j.contraception.2023.110001.
    >> Share

  174. WILKINSON TA, Meredith AH, Katz AJ, Meagher CG, et al
    Assessment of Adolescent Decision-Making Capacity for Pharmacy Access to Hormonal Contraception.
    Contraception. 2023 Mar 11:110002. doi: 10.1016/j.contraception.2023.110002.
    >> Share

  175. MERZ AA, Kerns JL, Logan R, Gutierrez S, et al
    Contraceptive care in the United States during the COVID-19 pandemic: a social media survey study of contraceptive access, telehealth use and telehealth quality.
    Contraception. 2023 Mar 3:110000. doi: 10.1016/j.contraception.2023.110000.
    >> Share

  176. ZUNIGA C, Blanchard K, Harper CC, Wollum A, et al
    Effectiveness and efficacy rates of progestin-only pills: A comprehensive literature review.
    Contraception. 2023;119:109925.
    >> Share

  177. BAUM SE, Sierra G, Grossman D, Vizcarra E, et al
    Comparing preference for and use of medication abortion in Texas after policy changes in 2014 and 2018.
    Contraception. 2023;119:109912.
    >> Share

  178. BAYARD KE, Fabricant SP, White JD, Gordon B, et al
    Infectious outcomes following immediate postplacental intrauterine device placement in the setting of chorioamnionitis: An exploratory, retrospective study.
    Contraception. 2023;119:109913.
    >> Share

  179. ARENA A, Moro E, Degli Esposti E, Zanello M, et al
    How much will it hurt? Factors associated with pain experience in women undergoing medication abortion during the first trimester.
    Contraception. 2023;119:109916.
    >> Share

  180. HAMRICK JE, Ahmed AE, Witkop CT, Manetz KE, et al
    Unintended pregnancy among U.S. military active duty servicemembers: Estimates for 2018 and trends since 2005.
    Contraception. 2023;119:109894.
    >> Share

    February 2023
  181. BURY F, Iguyovwe V, Trivett M, Baraitser P, et al
    Patterns of use of emergency and oral contraceptives from an online service in the UK during the COVID-19 pandemic: a quantitative study of routinely collected data.
    Contraception. 2023 Feb 25:109992. doi: 10.1016/j.contraception.2023.109992.
    >> Share

  182. THORNTON M, Arora KS
    Reproductive Justice in Post-Roe America: Impact of Restricted Abortion Access on Patients Seeking Permanent Contraception.
    Contraception. 2023 Feb 24:109995. doi: 10.1016/j.contraception.2023.109995.
    >> Share

  183. EDMONDSON S, Conrado AB, Loria H, McLeigh J, et al
    Caregivers of youth in foster care in Texas and their role in contraception decision-making for adolescents in care.
    Contraception. 2023 Feb 23:109993. doi: 10.1016/j.contraception.2023.109993.
    >> Share

  184. THOMPSON EL, Galvin AM, Ashvita Garg M, Diener A, et al
    A Socioecological Perspective to Contraceptive Access for Women Experiencing Homelessness in the United States.
    Contraception. 2023 Feb 23:109991. doi: 10.1016/j.contraception.2023.109991.
    >> Share

  185. CONGY J, Bouyer J, de La Rochebrochard E
    Low-income women and use of prescribed contraceptives in a context of full health insurance coverage in France, 2019.
    Contraception. 2023 Feb 7:109976. doi: 10.1016/j.contraception.2023.109976.
    >> Share

  186. BIGGS MA, Serrano S, Valladares ES, Grossman D, et al
    Development of a Spanish-language drug facts label prototype for a combination mifepristone and misoprostol medication abortion product.
    Contraception. 2023;118:109906.
    >> Share

  187. FAY KE, Traore F, Amico JR
    Intrauterine device self-removal practices during the COVID-19 pandemic among family planning clinics.
    Contraception. 2023;118:109889.
    >> Share

  188. MINNS A, Dehlendorf C, Peahl AF, Heisler M, et al
    Elevating the Patient Voice in Contraceptive Care Quality Improvement: A Qualitative Study of Patient Preferences for Peripastum Contraceptive Care.
    Contraception. 2023 Feb 1:109960. doi: 10.1016/j.contraception.2023.109960.
    >> Share

    January 2023
  189. AGARWAL K, Dewan R
    Evaluation of acceptability, safety and continuation rates of centchroman as post-abortion nonsteroidal contraceptive pill.
    Contraception. 2023 Jan 31:109961. doi: 10.1016/j.contraception.2023.109961.
    >> Share

  190. RODRIGUEZ MI, Daly A, Meath T, Watson K, et al
    Catholic sole community hospital s are associated with decreased receipt of postpartum permanent contraception among Medicaid recipients.
    Contraception. 2023 Jan 25:109959. doi: 10.1016/j.contraception.2023.109959.
    >> Share

  191. SALCEDO J, Cleland K, Bartz D, Thompson I, et al
    Society of Family Planning Clinical Recommendations: Emergency contraception.
    Contraception. 2023 Jan 21:109958. doi: 10.1016/j.contraception.2023.109958.
    >> Share

  192. MOSLEY EA, Monaco A, Zite N, Rosenfeld E, et al
    U.S. physicians' perspectives on the complexities and challenges of permanent contraception provision.
    Contraception. 2023 Jan 11:109948. doi: 10.1016/j.contraception.2023.109948.
    >> Share

  193. KEY K, Wollum A, Asetoyer C, Cervantes M, et al
    Challenges accessing contraceptive care and interest in over-the-counter oral contraceptive pill use among Black, Indigenous, and people of color: an online cross-sectional survey.
    Contraception. 2023 Jan 11:109950. doi: 10.1016/j.contraception.2023.109950.
    >> Share

  194. SARAYANI A, Winterstein A, Cristofoletti R, Vozmediano V, et al
    Real-World Effect of a Potential Drug-Drug Interaction Between Topiramate and Oral Contraceptives on Unintended Pregnancy Outcomes.
    Contraception. 2023 Jan 11:109953. doi: 10.1016/j.contraception.2023.109953.
    >> Share

  195. SCARSI KK, Smeaton LM, Podany AT, Olefsky M, et al
    Pharmacokinetics of dose-adjusted levonorgestrel emergency contraception combined with efavirenz-based antiretroviral therapy or rifampicin-containing tuberculosis regimens.
    Contraception. 2023 Jan 11:109951. doi: 10.1016/j.contraception.2023.109951.
    >> Share

  196. GUILLARD H, Laurora I, Sober S, Karapet A, et al
    Modeling the potential benefit of an over-the-counter progestin-only pill in preventing unintended pregnancies in the U.S.
    Contraception. 2023;117:7-12.
    >> Share

  197. GLASIER A, Edelman A, Creinin MD, Brache V, et al
    The effect of deliberate non-adherence to a norgestrel progestin-only pill: A randomized, crossover study.
    Contraception. 2023;117:1-6.
    >> Share

  198. LEE CM, Johns SL, Stulberg DB, Allen RH, et al
    Barriers to abortion provision in primary care in New England, 2019-2020: A qualitative study.
    Contraception. 2023;117:39-44.
    >> Share

    December 2022
  199. CARVAJAL D, Bevilacqua KG, Caldwell MT, Zambrana RE, et al
    Provider Perspectives on Patient-Centered Contraceptive Counseling for Latinas in Baltimore, MD.
    Contraception. 2022 Dec 16:109921. doi: 10.1016/j.contraception.2022.109921.
    >> Share

  200. BLACK KI, Trane W, Dorney E, Mola G, et al
    Corrigendum to "A cross-sectional study of factors associated with immediate postpartum uptake of contraceptive implants in Papua New Guinea" [Contraception 117C Pages 25-29].
    Contraception. 2022 Dec 15:109918. doi: 10.1016/j.contraception.2022.109918.
    >> Share

  201. QURESHY Z, Lokken RP, Kakar S, Grab J, et al
    Influence of Progestin-only Hormonal Use on Hepatocellular Adenomas: A Retrospective Cohort Study.
    Contraception. 2022 Dec 4:S0010-7824(22)00439.
    >> Share

  202. LAI R
    "Every Medicine Is Somewhat Poisonous": Understanding the Reluctance to Use Oral Contraceptives Among Unmarried Women Seeking Abortion in China.
    Contraception. 2022 Dec 3:S0010-7824(22)00437.
    >> Share

  203. HARADA T, Ota I, Kitawaki J, Momoeda M, et al
    Real-world outcomes of the levonorgestrel-releasing intrauterine system for heavy menstrual bleeding or dysmenorrhea in Japanese patients: A prospective observational study (J-MIRAI).
    Contraception. 2022;116:22-28.
    >> Share

  204. REYNOLDS-WRIGHT JJ, Woldetsadik MA, Morroni C, Cameron ST, et al
    Pain management for medical abortion before 14 weeks' gestation: A systematic review.
    Contraception. 2022;116:4-13.
    >> Share

    November 2022
  205. STEINER RJ, McDonald-Mosley R
    Over-the-counter oral contraception in the United States: An important opportunity at a time of increased concern about contraceptive access.
    Contraception. 2022 Nov 28:109911. doi: 10.1016/j.contraception.2022.
    >> Share

  206. SATHAR Z, Singh S, Hussain S, Sadiq M, et al
    FINANCING GAPS FOR PAKISTAN'S CONTRACEPTIVE PREVALENCE GOALS: ANALYSES USING THE GUTTMACHER ADDING-IT-UP METHODOLOGY.
    Contraception. 2022 Nov 26:S0010-7824(22)00433.
    >> Share

  207. HOLADAY LW, Gover M, Iyer SV, DeLuca JP, et al
    Effectiveness of training primary care internal medicine residents in etonogestrel implants and impact on their future practice: A cross-sectional study.
    Contraception. 2022;115:31-35.
    >> Share

  208. MANHART MD, Duane M
    A comparison of app-defined fertile days from two fertility tracking apps using identical cycle data.
    Contraception. 2022;115:12-16.
    >> Share

  209. KEMPPAINEN V, Mentula M, Palkama V, Heikinheimo O, et al
    Patient-controlled intravenous versus on-demand oral, intramuscular or mcs intravenous administration of oxycodone during medical induced abortion from 64 to 128 days of Gestation: A randomized controlled trial.
    Contraception. 2022;115:6-11.
    >> Share

  210. YOUNG D, Fitzgerald K, Laursen L, Whitaker AK, et al
    Comparison of vaginal and buccal misoprostol after mifepristone for medication abortion through 70 days of gestation: A retrospective chart review.
    Contraception. 2022;115:62-66.
    >> Share

    October 2022
  211. AVERBACH S, Johns NE, Ghule M, Dixit A, et al
    Understanding quality of contraceptive counseling in the CHARM2 gender-equity focused family planning intervention: findings from a cluster randomized controlled trial among couples in rural India.
    Contraception. 2022 Oct 31. pii: S0010-7824(22)00421.
    >> Share

  212. CHEN MJ, Jensen JT, Kaunitz AM, Achilles SL, et al
    Tolerability and safety of the estetrol/drospirenone combined oral contraceptive: Pooled analysis of two multicenter, open-label phase 3 trials.
    Contraception. 2022 Oct 15. pii: S0010-7824(22)00395.
    >> Share

  213. BLACK KI, Trane W, Dorney E, Mola G, et al
    A cross-sectional study of factors associated with immediate postpartum uptake of contraceptive implants in Papua New Guinea.
    Contraception. 2022 Oct 14. pii: S0010-7824(22)00390.
    >> Share

  214. GOYAL S, Monsour M, Ko JY, Curtis KM, et al
    Contraception claims by medication for opioid use disorder prescription status among insured women with opioid use disorder, United States, 2018.
    Contraception. 2022 Oct 12. pii: S0010-7824(22)00389.
    >> Share

  215. HOLT K, Karp C, Uttekar BV, Quintero X, et al
    Reduction of the Quality of Contraceptive Counseling (QCC) Scale to a Short Version (QCC-10) in Ethiopia, India, and Mexico.
    Contraception. 2022 Oct 12. pii: S0010-7824(22)00383.
    >> Share

  216. HENLEY C, Jenner E, Richardson B, Falk G, et al
    Non-Barrier Contraceptive Use Patterns Among Latina Adolescents Attending California Reproductive Health Centers: A Longitudinal Study.
    Contraception. 2022 Oct 11:9897. doi: 10.1016/j.contraception.2022.
    >> Share

  217. KAPLAN J, Turok DK, Gero A, Kaiser JE, et al
    Switching and discontinuation of participant-masked randomization to a copper or levonorgestrel intrauterine device when presenting for emergency contraception.
    Contraception. 2022 Oct 11. pii: S0010-7824(22)00386.
    >> Share

  218. WIMSETT DJ, Legget E, Roberts DH, Oyston DC, et al
    Factors associated with postpartum contraceptive planning in New Zealand.
    Contraception. 2022 Oct 11. pii: S0010-7824(22)00387.
    >> Share

  219. CROWE J, Cohen R
    Infected myometrial hematoma due to malpositioned levonorgestrel intrauterine device: A case report.
    Contraception. 2022;114:85-88.
    >> Share

  220. MILES C, Weidner A, Summit AK, Thomson CJ, et al
    Patient opinions on sexual and reproductive health services in primary care in rural and urban clinics.
    Contraception. 2022;114:26-31.
    >> Share

  221. ROTHSCHILD CW, Richardson BA, Guthrie BL, Drake AL, et al
    Trajectories of method dissatisfaction among Kenyan women using modern, reversible contraception: A prospective cohort study.
    Contraception. 2022 Oct 1. pii: S0010-7824(22)00380.
    >> Share

    September 2022
  222. LEE JK, Gutin SA, Getahun M, Okiring J, et al
    Condom, modern contraceptive, and dual method use are associated with HIV status and relationship concurrency in a context of high mobility: A cross-sectional study of women of reproductive age in rural Kenya and Uganda, 2016.
    Contraception. 2022 Sep 14. pii: S0010-7824(22)00248.
    >> Share

  223. KANGASNIEMI MH, Arffman RK, Haverinen A, Luiro K, et al
    Effects of estradiol- and ethinylestradiol-based contraceptives on adrenal steroids: A randomized trial.
    Contraception. 2022 Sep 6. pii: S0010-7824(22)00246.
    >> Share

  224. ENNIS M, Renner R, Guilbert E, Norman WV, et al
    Provision of first-trimester medication abortion in 2019: Results from the Canadian abortion provider survey.
    Contraception. 2022;113:19-25.
    >> Share

  225. CLERMIDY H, Fabre D, Hugues JN, Alonso CG, et al
    Management of Etonogestrel implant migration into the pulmonary artery.
    Contraception. 2022;113:62-67.
    >> Share

    August 2022
  226. HANSEN K, Boniface ER, Darney BG
    Association of Title X clinic status with receipt of person-centered contraceptive counseling: a population-based study.
    Contraception. 2022 Aug 19. pii: S0010-7824(22)00222.
    >> Share

  227. SWAN LET, Vu H, Higgins JA, Bui LM, et al
    Exploring financial stress and resource deprivation as barriers to preferred contraceptive use in Wisconsin in 2021.
    Contraception. 2022 Aug 5. pii: S0010-7824(22)00220.
    >> Share

  228. CEULEMANS M, Willekens J, Cavens L, De Wulf I, et al
    Knowledge and counseling preferences of the public and pharmacy staff on emergency contraception: results of a cross-sectional study in Belgium.
    Contraception. 2022 Aug 3. pii: S0010-7824(22)00217.
    >> Share

  229. ROMERO D, Manze M, Roberts L, McGroarty A, et al
    Stakeholder perspectives in New York State on reproductive health and pregnancy intention screening in primary care: A qualitative study.
    Contraception. 2022;112:93-99.
    >> Share

  230. BRADFORD RD, Farnsworth SJ, Laurora I, Sober S, et al
    Adherence among a cohort taking progestin-only pills prescribed by a healthcare provider: Results of the BENCHMARK study.
    Contraception. 2022;112:48-53.
    >> Share

  231. WESTHOFF CL, Archer DF, Barnhart K, Darney P, et al
    Evaluation of ovulation and safety outcomes in a multi-center randomized trial of three 84 day ulipristal acetate regimens.
    Contraception. 2022;112:54-60.
    >> Share

  232. KOHN JE, Berlan ED, Tang JH, Beasley A, et al
    Society of Family Planning committee consensus on self-administration of subcutaneous depot medroxyprogesterone acetate (DMPA-SC).
    Contraception. 2022;112:11-13.
    >> Share

  233. HAN L, Creinin MD, Hemon A, Glasier A, et al
    Mechanism of action of a 0.075 mg norgestrel progestogen-only pill 2. Effect on cervical mucus and theoretical risk of conception.
    Contraception. 2022;112:43-47.
    >> Share

  234. GLASIER A, Edelman A, Creinin MD, Han L, et al
    Mechanism of action of norgestrel 0.075 mg a progestogen-only pill. I. Effect on ovarian activity.
    Contraception. 2022;112:37-42.
    >> Share

  235. MILES C, Ennamuri D, Yeh J, Shih G, et al
    Would you be interested in DMPA-SC? An implementation project in two urban primary care clinics.
    Contraception. 2022;112:116-119.
    >> Share

    July 2022
  236. KAUNITZ AM, Achilles SL, Zatik J, Weyers S, et al
    Pooled analysis of two phase 3 trials evaluating the effects of a novel combined oral contraceptive containing estetrol/drospirenone on bleeding patterns in healthy women.
    Contraception. 2022 Jul 31. pii: S0010-7824(22)00218.
    >> Share

  237. JENSEN JT, Kaunitz AM, Achilles SL, Zatik J, et al
    Pooled efficacy results of estetrol/drospirenone combined oral contraception phase 3 trials.
    Contraception. 2022 Jul 31. pii: S0010-7824(22)00215.
    >> Share

  238. JONAS K, Lombard C, Chirinda W, Govindasamy D, et al
    Participation in an HIV prevention intervention and access to and use of contraceptives among young women: a cross sectional analysis in six South African districts.
    Contraception. 2022 Jul 23. pii: S0010-7824(22)00199.
    >> Share

  239. HASSELBACHER L, Moore A, Thompson L, Tyler CP, et al
    Exploring Illinois Contraceptive Providers' Interest in Medication Abortion Training.
    Contraception. 2022 Jul 20. pii: S0010-7824(22)00198.
    >> Share

  240. NGUYEN BT, Jacobsohn TL
    Post-abortion contraception, an opportunity for male partners and male contraception.
    Contraception. 2022 Jul 20. pii: S0010-7824(22)00195.
    >> Share

    June 2022
  241. TUMLINSON K, Britton LE, Williams CR, Wambua DM, et al
    Contraceptive method denial as downward contraceptive coercion: a mixed-methods mystery client study in Western Kenya.
    Contraception. 2022 Jun 29. pii: S0010-7824(22)00170.
    >> Share

  242. CLELAND K, Kumar B, Kakkad N, Shabazz J, et al
    Now Is the Time to Safeguard Access to Emergency Contraception Before Abortion Restrictions Sweep the United States.
    Contraception. 2022 Jun 23. pii: S0010-7824(22)00167.
    >> Share

  243. DETHIER D, Qasba N, Kaneshiro B
    Society of Family Planning Clinical Recommendation: Extended Use of Long Acting Reversible Contraception.
    Contraception. 2022 Jun 15. pii: S0010-7824(22)00162.
    >> Share

  244. MANCHIKANTI GOMEZ A, Rafie S, Garner-Ford E, Arcara J, et al
    Community Perspectives on Pharmacist-Prescribed Hormonal Contraception in Rural California.
    Contraception. 2022 Jun 4. pii: S0010-7824(22)00153.
    >> Share

  245. FRIEDLANDER EB, Raidoo S, Soon R, Salcedo J, et al
    The experience of pain in real-time during medication abortion.
    Contraception. 2022;110:71-75.
    >> Share

  246. WHITEHOUSE KC, Shochet T, Lohr PA
    Efficacy of a low-sensitivity urine pregnancy test for identifying ongoing pregnancy after medication abortion at 64 to 70 days of gestation.
    Contraception. 2022;110:21-26.
    >> Share

  247. DUIJKERS IJM, Klipping C, Rautenberg T, Schug BS, et al
    Effect on ovarian activity and ovulation inhibition of different oral dosages of levonorgestrel.
    Contraception. 2022;110:6-15.
    >> Share

  248. CADDY C, Williams H, Hocking J, Coombe J, et al
    "I never went to see that doctor again": A qualitative study examining Australian women's experiences requesting removal of LARC within 12 months of insertion.
    Contraception. 2022;110:81-85.
    >> Share

    May 2022
  249. CREININ MD, Vieira CS, Westhoff CL, Mansour DJA, et al
    Recommendations for standardization of bleeding data analyses in contraceptive studies.
    Contraception. 2022 May 28. pii: S0010-7824(22)00152.
    >> Share

  250. WOODHAMS E, Samura T, White K, Patton E, et al
    Society of Family Planning Clinical Recommendations: Contraception and abortion care for persons who use substances.
    Contraception. 2022 May 26. pii: S0010-7824(22)00151.
    >> Share

  251. REED R, Osby O, Nelums M, Welchlin C, et al
    Contraceptive care experiences and preferences among Black women in Mississippi: A qualitative study.
    Contraception. 2022 May 26. pii: S0010-7824(22)00140.
    >> Share

  252. STIFANI BM, Madden T, Micks E, Moayedi G, et al
    Society of Family Planning Clinical Recommendations: Contraceptive Care in the Context of Pandemic Response.
    Contraception. 2022 May 17. pii: S0010-7824(22)00138.
    >> Share

  253. KOCH SK, Paul R, Addante AN, Brubaker A, et al
    Medicaid Reimbursement Program for Immediate Postpartum Long-Acting Reversible Contraception Improves Uptake Regardless of Insurance Status.
    Contraception. 2022 May 16. pii: S0010-7824(22)00137.
    >> Share

  254. AHMAD ZM, Noel NL, Rudd TM, Nadelson CS, et al
    Implementation of a Pharmacist-led Hormonal Contraceptive Prescribing Service in a Campus Community Pharmacy in Indiana, United States.
    Contraception. 2022 May 13. pii: S0010-7824(22)00133.
    >> Share

  255. SACK DE, Peetluk LS, Audet CM
    Couples-based interventions and postpartum contraceptive uptake: a systematic review.
    Contraception. 2022 May 13. pii: S0010-7824(22)00131.
    >> Share

  256. HELLWIG F, Ewerling F, Coll CVN, Barros AJD, et al
    The role of female permanent contraception in meeting the demand for family planning in low- and middle-income countries.
    Contraception. 2022 May 11. pii: S0010-7824(22)00135.
    >> Share

  257. JACOBSOHN T, Nguyen BT, Brown JE, Thirumalai A, et al
    Male Contraception is Coming: Who Do Men Want to Prescribe their Birth Control?
    Contraception. 2022 May 9. pii: S0010-7824(22)00132.
    >> Share

  258. MASTEN M, Larrea N, Schultz C, Lazorwitz A, et al
    Short-notice cancellations of laparoscopic permanent contraception.
    Contraception. 2022 May 8. pii: S0010-7824(22)00130.
    >> Share

  259. SOIN KS, Yeh PT, Gaffield ME, Ge C, et al
    Health workers' values and preferences regarding contraceptive methods globally: a systematic review.
    Contraception. 2022 May 5. pii: S0010-7824(22)00129.
    >> Share

  260. YEH PT, Kautsar H, Kennedy CE, Gaffield ME, et al
    Values and preferences for contraception: a global systematic review.
    Contraception. 2022 May 4. pii: S0010-7824(22)00128.
    >> Share

  261. ADASHI EY, Rajan RS, O'Mahony DP, Cohen IG, et al
    The next two decades of mifepristone at FDA: History as destiny().
    Contraception. 2022;109:1-7.
    >> Share

  262. RAZON N, Wulf S, Perez C, McNeil S, et al
    Exploring the impact of mifepristone's risk evaluation and mitigation strategy (REMS) on the integration of medication abortion into US family medicine primary care clinics,.
    Contraception. 2022;109:19-24.
    >> Share

  263. JARIENE K, Ulevicius J, Petrusaite A, Sirataviciene A, et al
    Sexual behavior of Lithuanian high school students.
    Contraception. 2022;109:62-67.
    >> Share

  264. BIGGS MA, Ralph L, Morris N, Ehrenreich K, et al
    A cross-sectional survey of U.S. abortion patients' interest in obtaining medication abortion over the counter.
    Contraception. 2022;109:25-31.
    >> Share

  265. FOSTER AM, Messier K, Aslam M, Shabir N, et al
    Community-based distribution of misoprostol for early abortion: Outcomes from a program in Sindh, Pakistan.
    Contraception. 2022;109:49-51.
    >> Share

  266. RUSSELL CB, Qasba N, Evans ML, Frankel A, et al
    Variation in the interpretation and application of the Medicaid sterilization consent form among Medicaid officials.
    Contraception. 2022;109:57-61.
    >> Share

  267. LAROCHE KJ, Wylie A, Persaud M, Foster AM, et al
    Integrating mifepristone into primary care in Canada's capital: A multi-methods exploration of the Medical Abortion Access Project.
    Contraception. 2022;109:37-42.
    >> Share

  268. BYRNE JJ, Smith EM, Saucedo AM, Doody KA, et al
    Accessibility to postpartum tubal ligation after a vaginal delivery: When the Medicaid policy is not a limiting factor.
    Contraception. 2022;109:52-56.
    >> Share

    April 2022
  269. MCCOOL-MYERS M, Kozlowski D, Jean V, Cordes S, et al
    The COVID-19 pandemic's impact on sexual and reproductive health in Georgia, USA: An exploration of behaviors, contraceptive care, and partner abuse.
    Contraception. 2022 Apr 27. pii: S0010-7824(22)00126.
    >> Share

  270. BURKE HM, Packer C, Fuchs R, Brache V, et al
    Acceptability of the contraceptive Sayana(R) Press when injected every four months: Results from a 12-month trial in Brazil, Chile and the Dominican Republic.
    Contraception. 2022 Apr 26. pii: S0010-7824(22)00124.
    >> Share

  271. STORCK KE, Gawron LM, Sanders JN, Wiaderny N, et al
    "I just had to pay the money and be supportive": A qualitative exploration of the male-partner role in contraceptive decision-making in Salt Lake City, Utah family planning clinics.
    Contraception. 2022 Apr 22. pii: S0010-7824(22)00109.
    >> Share

  272. MONIZ MH, Spector-Bagdady K, Perritt JB, Heisler M, et al
    Balancing Enhanced Contraceptive Access with Risk of Reproductive Injustice: A United States Comparative Case Study.
    Contraception. 2022 Apr 16. pii: S0010-7824(22)00105.
    >> Share

  273. MANZER JL, Berndt VK, Bell AV
    Comparing methods of long-acting reversible contraception: A qualitative study of Delaware women's perceptions of intrauterine devices and the implant.
    Contraception. 2022 Apr 10. pii: S0010-7824(22)00104.
    >> Share

  274. HARGRAVE AS, Ong A, Raza Z, Franco C, et al
    Opportunities for improving provision of emergency contraception in California.
    Contraception. 2022 Apr 2. pii: S0010-7824(22)00102.
    >> Share

  275. LEROY L, West AM, Hall C, Thomas D, et al
    A Real-World Comparison of In-Person vs. Virtual Contraceptive Care Trainings for Clinicians and Support Staff.
    Contraception. 2022 Apr 1. pii: S0010-7824(22)00082.
    >> Share

  276. RODRIGUEZ MI, Skye M, Samandari G, Darney BG, et al
    Timing of postpartum long acting, reversible contraception was not associated with 12-month removal rates in a large Medicaid sample.
    Contraception. 2022 Apr 1. pii: S0010-7824(22)00080.
    >> Share

  277. GILBERT AL, Amico JR
    Dilation and evacuation with an abdominal cerclage at 21 weeks gestation: A case report.
    Contraception. 2022;108:78-79.
    >> Share

  278. DRAGOMAN M, Fofie C, Bergen S, Chavkin W, et al
    Integrating self-managed medication abortion with medical care.
    Contraception. 2022;108:1-3.
    >> Share

    March 2022
  279. WU JP, Johnson E, Taichman LS
    Contraceptive decisions among individuals with medical conditions in Michigan, USA: A qualitative explanatory model informed by the Health Belief Model and the principle of respect for patient autonomy.
    Contraception. 2022 Mar 26. pii: S0010-7824(22)00084.
    >> Share

  280. MELBOSTAD HS, Wachtel DS, Lipke KA, Badger GJ, et al
    Preliminary Side Effect Profile, Safety, and Tolerability of Hormonal Contraception Among Women Receiving Opioid-Agonist Therapy.
    Contraception. 2022 Mar 10. pii: S0010-7824(22)00061.
    >> Share

  281. HURTADO ACM, Crowley SM, Landry KM, Landry MS, et al
    Telehealth Contraceptive Care in 2018: A Quality Improvement Study of Barriers to Access and Patient Satisfaction.
    Contraception. 2022 Mar 6. pii: S0010-7824(22)00059.
    >> Share

  282. ELIASON EL, Spishak-Thomas A, Steenland MW
    Title: Association of the Affordable Care Act Medicaid Expansions with Postpartum Contraceptive Use and Early Postpartum Pregnancy.
    Contraception. 2022 Mar 5. pii: S0010-7824(22)00060.
    >> Share

  283. JOHNSON ER
    Healthcare Access and Contraceptive Use among Adult Women in the United States in 2017.
    Contraception. 2022 Mar 3. pii: S0010-7824(22)00056.
    >> Share

  284. SHIN RJ, Yao M, Akesson C, Blazel M, et al
    An exploratory study comparing the quality of contraceptive counseling provided via telemedicine versus in-person visits.
    Contraception. 2022 Mar 2. pii: S0010-7824(22)00053.
    >> Share

  285. DOAN YP, Lehman EB, Chuang CH
    Effect of Neighborhood-Level Income on Access to Emergency Contraception.
    Contraception. 2022 Mar 2. pii: S0010-7824(22)00054.
    >> Share

  286. WIMSETT DJ, Sadler DL, Tutty DS, Tutty DE, et al
    Pregnancy planning and barriers to accessing postnatal contraception in New Zealand.
    Contraception. 2022 Mar 2. pii: S0010-7824(22)00055.
    >> Share

  287. UHM S, Mastey N, Baker CC, Chen MJ, et al
    Mifepristone prior to osmotic dilators for dilation and evacuation cervical preparation: A randomized, double-blind, placebo-controlled pilot study.
    Contraception. 2022;107:23-28.
    >> Share

  288. GROSSMAN D, Raifman S, Morris N, Arena A, et al
    Mail-order pharmacy dispensing of mifepristone for medication abortion after in-person clinical assessment.
    Contraception. 2022;107:36-41.
    >> Share

  289. SHAY RL, Benson LS, Lokken EM, Micks EA, et al
    Same-day mifepristone prior to second-trimester induction termination with misoprostol: A retrospective cohort study.
    Contraception. 2022;107:29-35.
    >> Share

    February 2022
  290. DEHINGIA N, Barker KM, Raj A
    Relationship between adolescent friendship networks and contraceptive use and unintended pregnancies in early adulthood in the United States.
    Contraception. 2022 Feb 21. pii: S0010-7824(22)00032.
    >> Share

  291. CHOGLUECK C
    The FDA ought to change Plan B's label.
    Contraception. 2022;106:6-9.
    >> Share

  292. CREININ M, Kohn JE, Tang JH, Serna TB, et al
    Society of Family Planning Committee statement on IUD nomenclature.
    Contraception. 2022;106:1-2.
    >> Share

    January 2022
  293. KUMNICK A, Hanfling SN, Dowlut-McElroy T, Maher JY, et al
    An Intersectional Analysis of Contraceptive Types Chosen Among Sexual Minority Women: A Nationally Representative Study.
    Contraception. 2022 Jan 24. pii: S0010-7824(22)00009.
    >> Share

  294. KAKAR V, Kulkarni A, Holschuh C, Smirnova A, et al
    Contraception Information on the Websites of Student Health Centers in the United States.
    Contraception. 2022 Jan 24. pii: S0010-7824(22)00011.
    >> Share

  295. LERMA K, McBrayer A, Nathan S, Dehlendorf C, et al
    Use of a contraceptive decision support tool in the abortion care setting.
    Contraception. 2022 Jan 23. pii: S0010-7824(22)00010.
    >> Share

  296. ENDLER M, Li R, Gemzell-Danielsson K
    Effect of levonorgestrel emergency contraception on implantation and fertility: a review.
    Contraception. 2022 Jan 23. pii: S0010-7824(22)00006.
    >> Share

  297. THORMAN A, Engle A, Brintz B, Simmons RG, et al
    Quantitative and qualitative impact of One Key Question(R) on primary care providers' contraceptive counseling at routine preventive health visits.
    Contraception. 2022 Jan 14. pii: S0010-7824(22)00003.
    >> Share

  298. KAMUYANGO A, Yu T, Ao CK, Hu SC, et al
    The public-sector family planning program impact scores in association with long acting reversible contraceptive use among young women in 22 Sub-Saharan African countries; A pooled multi-level analysis.
    Contraception. 2022 Jan 11. pii: S0010-7824(21)00497.
    >> Share

  299. WALLACE R, Shih G
    Complex family planning - Demarginalizing abortion care requires uplifting primary care and non-CFP providers.
    Contraception. 2022;105:86.
    >> Share

  300. SINKEY RG, Blanchard CT, Maier J, Novara A, et al
    The effects of offering immediate postpartum placement of IUDs and implants to pregnant patients with heart disease.
    Contraception. 2022;105:55-60.
    >> Share

  301. GLASIER A, Sober S, Gasloli R, Goyal A, et al
    A review of the effectiveness of a progestogen-only pill containing norgestrel 75 microg/day.
    Contraception. 2022;105:1-6.
    >> Share

    December 2021
  302. LAZORWITZ A, Sheeder J, Teal S
    Variability in repeat serum etonogestrel concentrations among contraceptive implant users during the steady-release pharmacokinetic period.
    Contraception. 2021 Dec 29. pii: S0010-7824(21)00463.
    >> Share

  303. RODRIGUEZ MI, Skye M, Ramanadhan S, Schrote K, et al
    Examining the association between short interpregnancy interval births and the type and timing of postpartum long acting reversible contraception.
    Contraception. 2021 Dec 28. pii: S0010-7824(21)00475.
    >> Share

  304. THOMPSON RL, Hu J, Custodio P, Dart C, et al
    The use of serum segesterone acetate levels to assess adherence of trial participants with a contraceptive vaginal ring.
    Contraception. 2021 Dec 28. pii: S0010-7824(21)00477.
    >> Share

  305. MANN ES, Chen AM, Johnson CL
    Doctor Knows Best? Provider Bias in the Context of Contraceptive Counseling in the United States.
    Contraception. 2021 Dec 28. pii: S0010-7824(21)00472.
    >> Share

  306. CHRISTINE BE, Rose M, Victoria Z, P H, et al
    Comparing perceptions of long-acting reversible contraception among women during periods of incarceration and women attending a local clinic; an exploratory study.
    Contraception. 2021 Dec 28. pii: S0010-7824(21)00480.
    >> Share

  307. KAWATU J, Clark M, Saul K, Quimby KD, et al
    Increasing access to single-visit contraception in urban health care settings: Findings from a multi-site learning collaborative.
    Contraception. 2021 Dec 28. pii: S0010-7824(21)00465.
    >> Share

  308. ROLAND N, Drouin J, Desplas D, Duranteau L, et al
    Impact of Coronavirus Disease 2019 (COVID-19) On Contraception Use in 2020 and up until the end of April 2021 in France.
    Contraception. 2021 Dec 28. pii: S0010-7824(21)00464.
    >> Share

  309. CHALMIERS MA, Karaki F, Muriki M, Mody S, et al
    Refugee women's experiences with contraceptive care after resettlement in high-income countries: A Critical Interpretive Synthesis.
    Contraception. 2021 Dec 28. pii: S0010-7824(21)00466.
    >> Share

  310. FOSTER DG, Gould H, Biggs MA
    Timing of pregnancy discovery among women seeking abortion().
    Contraception. 2021;104:642-647.
    >> Share

  311. ANGER HA, Raymond EG, Grant M, Haskell S, et al
    Clinical and service delivery implications of omitting ultrasound before medication abortion provided via direct-to-patient telemedicine and mail in the U.S.
    Contraception. 2021;104:659-665.
    >> Share

  312. SHERPA LY, Tinkari BS, Gentle P, Sah RK, et al
    A prospective cohort study to assess the acceptability of Sayana Press among 18-49-year-old women in Nepal.
    Contraception. 2021;104:623-627.
    >> Share

    November 2021
  313. BEESHAM I, Bosman S, Beksinska M, Scoville CW, et al
    Contraceptive method preference and reasons for contraceptive discontinuation among women randomized to intramuscular depot medroxyprogesterone acetate, a copper intrauterine device or a levonorgestrel implant: Findings from Durban, South Africa.
    Contraception. 2021 Nov 27. pii: S0010-7824(21)00447.
    >> Share

  314. BERGLIN M, Stram D, Stenquist A, Dessi S, et al
    INTRAUTERINE DEVICE, SUBDERMAL CONTRACEPTIVE, AND DEPOT MEDROXYPROGESTERONE USE AMONG TRANSMASCULINE AND CISGENDER PATIENTS OVER A 10-YEAR PERIOD.
    Contraception. 2021 Nov 27. pii: S0010-7824(21)00448.
    >> Share

  315. ANASTASIOU E, McCarthy KJ, Gollub EL, Ralph L, et al
    The relationship between hormonal contraception and cervical dysplasia/cancer controlling for human papillomavirus infection: a systematic review.
    Contraception. 2021 Nov 6. pii: S0010-7824(21)00445.
    >> Share

  316. WONG ZJ, Thompson L, Boulware A, Chen J, et al
    What You Don't Know Can Hurt You: Patient and Provider Perspectives on Postpartum Contraceptive Care in Illinois Catholic Hospitals.
    Contraception. 2021 Nov 5. pii: S0010-7824(21)00437.
    >> Share

  317. LI R, Ellington SR, Galang RR, Grosse SD, et al
    Economic evaluation of Zika Contraception Access Network in Puerto Rico during the 2016-17 Zika virus outbreak.
    Contraception. 2021 Nov 5. pii: S0010-7824(21)00440.
    >> Share

  318. LUNDBERG BR, Tabuyo-Martin A, Ponzini MD, Wilson MD, et al
    Contraceptive plans before pre-operative assessment and at procedure in surgical abortion patients.
    Contraception. 2021 Nov 5. pii: S0010-7824(21)00444.
    >> Share

  319. JARUAMORNJIT Y, Kaewrudee S, Sothornwit J
    Differences in postpartum contraceptive choices and patterns following low- and high-risk pregnancy.
    Contraception. 2021 Nov 5. pii: S0010-7824(21)00442.
    >> Share

  320. HOPKINS K, Remington C, Eilers MA, Rivas SD, et al
    Obtaining buy-in for immediate postpartum long-acting reversible contraception programs in Texas hospitals: A qualitative study.
    Contraception. 2021 Nov 5. pii: S0010-7824(21)00434.
    >> Share

  321. SALEEM HT, Rosen JG, Quinn C, Duggaraju A, et al
    Contraception values and preferences of people living with HIV: a systematic review.
    Contraception. 2021 Nov 5. pii: S0010-7824(21)00433.
    >> Share

  322. DAM A, Yeh PT, Burke AE, Kennedy CE, et al
    Contraceptive values and preferences of pregnant women, postpartum women, women seeking emergency contraceptives, and women seeking abortion services: a systematic review.
    Contraception. 2021 Nov 3. pii: S0010-7824(21)00439.
    >> Share

  323. NIU F, Cornelius J, Aboubechara N, Saraj A, et al
    Real world outcomes related to providing an annual supply of short-acting hormonal contraceptives.
    Contraception. 2021 Nov 3. pii: S0010-7824(21)00435.
    >> Share

  324. EL-HADAD S, Villars P, Kahr MK, Leeners B, et al
    Removal of nonpalpable etonogestrel implants after fixation with a curved needle-A case series().
    Contraception. 2021;104:577-580.
    >> Share

  325. WHITE AL, Mann ES, Billings DL, Shah P, et al
    A qualitative exploration of men's perceptions of the terms "male sterilization" versus "vasectomy" in the southern United States.
    Contraception. 2021;104:524-530.
    >> Share

  326. GLASER K, Fix M, Karlin J, Schwarz EB, et al
    Awareness of the option of IUC self-removal among US adolescents.
    Contraception. 2021;104:567-570.
    >> Share

  327. HORGAN P, Thompson M, Harte K, Gee R, et al
    Termination of pregnancy services in Irish general practice from January 2019 to June 2019.
    Contraception. 2021;104:502-505.
    >> Share

    October 2021
  328. KWAL J, Maguire K, Carugno J
    Localization and Management of Nonpalpable Radiopaque Contraceptive Implant.
    Contraception. 2021 Oct 11. pii: S0010-7824(21)00412.
    >> Share

  329. JIAQI X, Shuxian W, Linlin Y, Li L, et al
    Does China's universal two-child policy affect contraceptive use among internal migrant women in China? Evidence based on panel data.
    Contraception. 2021 Oct 6. pii: S0010-7824(21)00404.
    >> Share

  330. DIMENSTEIN NB, Lindberg LD, Arrington-Sanders R, Jennings JM, et al
    Exploring experience of and engagement in coercive pregnancy behaviors among sexually active young men from five clinics in Baltimore, MD.
    Contraception. 2021;104:367-371.
    >> Share

  331. CHATROUX L, Darney BG, Skye M, Caughey AB, et al
    Examining the effect of unintended pregnancy on health utility using four measures.
    Contraception. 2021;104:344-349.
    >> Share

  332. ROE AH, McAllister A, Flynn AN, Martin B, et al
    The effect of mifepristone pretreatment on bleeding and pain during medical management of early pregnancy loss.
    Contraception. 2021;104:432-436.
    >> Share

  333. KLANGSIN S, Suwanrath C, Wattanakumtornkul S
    A case report of eosinophilia associated with an etonogestrel implant.
    Contraception. 2021;104:442-443.
    >> Share

    September 2021
  334. KAPLAN S, Bertoia ML, Wang FT, Zhou L, et al
    Long-term safety of extended levonorgestrel-containing oral contraceptives in the United States.
    Contraception. 2021 Sep 29. pii: S0010-7824(21)00406.
    >> Share

  335. RAINE-BENNETT T, Fassett MJ, Chandra M, Armstrong MA, et al
    Ectopic Pregnancy Prevention: Further Evidence of Benefits of Prescription Contraceptives.
    Contraception. 2021 Sep 18. pii: S0010-7824(21)00383.
    >> Share

  336. TEBB KP, Dehlendorf C, Rodriguez F, Fix M, et al
    Promoting Teen-to-Teen Contraceptive Communication with the SpeakOut Intervention, a Cluster Randomized Trial.
    Contraception. 2021 Sep 11. pii: S0010-7824(21)00377.
    >> Share

  337. BRINGLEY J, Zu V, Javlekar A, Daoud-Yilmaz F, et al
    Effects of Rotating at a Catholic Hospital on Medical Student Contraceptive Objective Structured Clinical Exam Scores.
    Contraception. 2021 Sep 7. pii: S0010-7824(21)00378.
    >> Share

  338. FURLAN RM, Garcia E, Castro S, Machado HC, et al
    Expulsion rates of the levonorgestrel 52 mg intrauterine system are similar among women with heavy menstrual bleeding and users for contraception.
    Contraception. 2021 Sep 5. pii: S0010-7824(21)00374.
    >> Share

  339. SILVERSTEIN RG, Fitz V, Thornton M, Carter A, et al
    Contraceptive use and counseling in patients with systemic lupus erythematosus.
    Contraception. 2021 Sep 4. pii: S0010-7824(21)00376.
    >> Share

  340. SHELEF DQ, Raine-Bennett T, Chandra M, Adler N, et al
    The association between depression and contraceptive behaviors in a diverse sample of new prescription contraception users.
    Contraception. 2021 Sep 2. pii: S0010-7824(21)00373.
    >> Share

  341. FOK WK, Lerma K, Shaw KA, Blumenthal PD, et al
    Comparison of two home pregnancy tests for self-confirmation of medication abortion status: A randomized trial.
    Contraception. 2021;104:296-300.
    >> Share

    August 2021
  342. DIAMOND-SMITH N, Logan R, Marshall C, Corbetta-Rastelli C, et al
    COVID-19's impact on contraception experiences: exacerbation of structural inequities in women's health.
    Contraception. 2021 Aug 27. pii: S0010-7824(21)00369.
    >> Share

  343. ROE AH, Lang B, McAllister A, Gaitors MC, et al
    Contraceptive use and preferences among females with sickle cell disease.
    Contraception. 2021 Aug 18. pii: S0010-7824(21)00353.
    >> Share

  344. KREITCHMANN R, Stek A, Best BM, Capparelli E, et al
    Interactions Between Etonogestrel-Releasing Contraceptive Implant and Three Antiretroviral Regimens.
    Contraception. 2021 Aug 15. pii: S0010-7824(21)00350.
    >> Share

  345. STEENLAND MW, Geiger CK, Chen L, Rokicki S, et al
    Declines in Contraceptive Visits in the United States during the COVID-19 Pandemic.
    Contraception. 2021 Aug 14. pii: S0010-7824(21)00347.
    >> Share

  346. THOMPSON K, Kirschner JH, Irwin S, Lee A, et al
    Perceptions of Long-acting Reversible Contraception among Women in an Urban U.S. Jail.
    Contraception. 2021 Aug 13. pii: S0010-7824(21)00345.
    >> Share

  347. PAN YL, Beal L, Espino K, Sufrin CB, et al
    Female Permanent Contraception Policies and Occurrence at a Sample of U.S. Prisons and Jails.
    Contraception. 2021 Aug 13. pii: S0010-7824(21)00349.
    >> Share

  348. BROUSSARD K, Becker A
    Self-removal of long-acting reversible contraception: A content analysis of YouTube videos.
    Contraception. 2021 Aug 13. pii: S0010-7824(21)00346.
    >> Share

  349. CREININ MD
    Ethinyl estradiol and levonorgestrel patch phase 3 data clarification.
    Contraception. 2021;104:216.
    >> Share

  350. NELSON AL
    Author response to ethinyl estradiol and levonorgestrel Phase 3 data clarification.
    Contraception. 2021;104:217.
    >> Share

  351. LATACK KR, Patel J, Moog D, Spencer D, et al
    Withdrawal method inquiries and user experiences: An analysis of content posted on 4 gendered forums on Reddit.
    Contraception. 2021;104:170-175.
    >> Share

    July 2021
  352. AHRENS K, Skjeldestad FE
    Trends in initiation of hormonal contraceptive methods among teenagers born between 1989 and 1997 in Norway and the United States.
    Contraception. 2021 Jul 27. pii: S0010-7824(21)00339.
    >> Share

  353. WILKINSON TA, Edmonds BT, Cheng ER
    Outcomes of a Two-Visit Protocol for Long Acting Reversible Contraception for Adolescents and Young Adults.
    Contraception. 2021 Jul 27. pii: S0010-7824(21)00341.
    >> Share

  354. BROWN HK, Aker A, Wanigaratne S
    Multimorbidity and use of reversible contraception: Results from a Canadian cross-sectional survey.
    Contraception. 2021 Jul 27. pii: S0010-7824(21)00343.
    >> Share

  355. HARRISON MS, Jimenez-Zambrano A, Rivera C, Bunge-Montes S, et al
    Delivery of home-based postpartum contraception in Southwest Trifinio, Guatemala: reach, adoption, and implementation in a cluster-randomized trial.
    Contraception. 2021 Jul 13. pii: S0010-7824(21)00223.
    >> Share

  356. BARBOSA RM, Kalckmann S, Arilha M, Giacomodo Lago TD, et al
    The emergency contraceptive pill in Brazil: high usage rates but schooling differences persist.
    Contraception. 2021 Jul 2. pii: S0010-7824(21)00219.
    >> Share

  357. RODRIGUEZ MI, Meath T, Huang J, Darney BG, et al
    Association of rural location and long acting reversible contraceptive use among Oregon Medicaid recipients.
    Contraception. 2021 Jul 2. pii: S0010-7824(21)00218.
    >> Share

  358. DOHM J, Ji M
    An introduction to risk evaluation and mitigation strategies.
    Contraception. 2021;104:4-7.
    >> Share

  359. MARK A, Foster AM, Perritt J
    The future of abortion is now: Mifepristone by mail and in-clinic abortion access in the United States.
    Contraception. 2021;104:38-42.
    >> Share

  360. SERPICO JJ
    Abortion exceptionalism and the mifepristone REMS.
    Contraception. 2021;104:8-11.
    >> Share

  361. KERESTES C, Murayama S, Tyson J, Natavio M, et al
    Provision of medication abortion in Hawai'i during COVID-19: Practical experience with multiple care delivery models.
    Contraception. 2021;104:49-53.
    >> Share

  362. CHONG E, Shochet T, Raymond E, Platais I, et al
    Expansion of a direct-to-patient telemedicine abortion service in the United States and experience during the COVID-19 pandemic.
    Contraception. 2021;104:43-48.
    >> Share

  363. CLELAND K, Foster AM, Gomez AM, Raymond EG, et al
    Contraception Special Issue on the mifepristone Risk Evaluation and Mitigation Strategy (REMS).
    Contraception. 2021;104:1-3.
    >> Share

  364. THOMPSON A, Singh D, Ghorashi AR, Donovan MK, et al
    The disproportionate burdens of the mifepristone REMS.
    Contraception. 2021;104:16-19.
    >> Share

  365. MEURICE ME, Whitehouse KC, Blaylock R, Chang JJ, et al
    Client satisfaction and experience of telemedicine and home use of mifepristone and misoprostol for abortion up to 10 weeks' gestation at British Pregnancy Advisory Service: A cross-sectional evaluation.
    Contraception. 2021;104:61-66.
    >> Share

  366. STONE RH, Rafie S
    Medication abortion: Advocating for mifepristone dispensing by pharmacists.
    Contraception. 2021;104:31-32.
    >> Share

  367. KAYE J, Reeves R, Chaiten L
    The mifepristone REMS: A needless and unlawful barrier to care.
    Contraception. 2021;104:12-15.
    >> Share

  368. SRINIVASULU S, Yavari R, Brubaker L, Riker L, et al
    US clinicians' perspectives on how mifepristone regulations affect access to medication abortion and early pregnancy loss care in primary care.
    Contraception. 2021;104:92-97.
    >> Share

  369. CALLOWAY D, Stulberg DB, Janiak E
    Mifepristone restrictions and primary care: Breaking the cycle of stigma through a learning collaborative model in the United States.
    Contraception. 2021;104:24-28.
    >> Share

  370. RAIDOO S, Kaneshiro B, Stowers P
    Guam: The US territory where America's day begins but abortion access is still in the dark.
    Contraception. 2021;104:33-35.
    >> Share

  371. GLASER K, Whitehair J
    Missing mifepristone at tribal health facilities serving native Americans.
    Contraception. 2021;104:36-37.
    >> Share

  372. DANIEL S, Schulkin J, Grossman D
    Obstetrician-gynecologist willingness to provide medication abortion with removal of the in-person dispensing requirement for mifepristone.
    Contraception. 2021;104:73-76.
    >> Share

  373. RASMUSSEN KN, Janiak E, Cottrill AA, Stulberg DB, et al
    Expanding access to medication abortion through pharmacy dispensing of mifepristone: Primary care perspectives from Illinois.
    Contraception. 2021;104:98-103.
    >> Share

    June 2021
  374. FAY KE, Clement AC, Gero A, Kaiser JE, et al
    Rates of pregnancy among levonorgestrel and copper intrauterine emergency contraception initiators: implications for backup contraception recommendations.
    Contraception. 2021 Jun 21. pii: S0010-7824(21)00210.
    >> Share

  375. BRACHE V, Vieira CS, Plagianos M, Lansiaux M, et al
    Pharmacodynamics and pharmacokinetics of a copper intrauterine contraceptive system releasing ulipristal acetate: a randomized proof-of-concept study.
    Contraception. 2021 Jun 19. pii: S0010-7824(21)00193.
    >> Share

  376. NGUYEN BT, Yuen F, Farrant M, Thirumalai A, et al
    Acceptability of the oral hormonal male contraceptive prototype, 11beta-Methyl-19-nortestosterone dodecylcarbonate (11beta-MNTDC), in a 28-day placebo-controlled trial.
    Contraception. 2021 Jun 18. pii: S0010-7824(21)00192.
    >> Share

  377. LAVELANET AF, Ralph JA, Ti A, Duggaraju A, et al
    A systematic review exploring the contraception values and preferences of sex workers, transmasculine individuals, people who inject drugs, and those living in humanitarian contexts.
    Contraception. 2021 Jun 18. pii: S0010-7824(21)00191.
    >> Share

  378. LEW J, Sheeder J, Lazorwitz A
    Etonogestrel contraceptive implant uptake and safety among solid organ transplant recipients.
    Contraception. 2021 Jun 17. pii: S0010-7824(21)00190.
    >> Share

  379. ZEAL C, Paul R, Dorsey M, Politi MC, et al
    Young women's preferences for contraceptive education: the importance of the clinician.
    Contraception. 2021 Jun 14. pii: S0010-7824(21)00188.
    >> Share

  380. NGUYEN BT, Brown AL, Jones F, Jones L, et al
    "I'm not going to be a guinea pig:" medical mistrust as a barrier to male contraception for Black American men in Los Angeles, CA.
    Contraception. 2021 Jun 9. pii: S0010-7824(21)00184.
    >> Share

  381. GYLLENBERG F, Tekay A, Saloranta T, Korjamo R, et al
    CONTRACEPTIVE PRIORITIES AMONG WOMEN SEEKING FAMILY PLANNING SERVICES IN FINLAND IN 2017-2019.
    Contraception. 2021 Jun 9. pii: S0010-7824(21)00186.
    >> Share

  382. SOBEL L, Lee YW, White KO, Woodhams E, et al
    Contraceptive decision making among pregnancy-capable individuals with opioid use disorder at a tertiary care center in Massachusetts.
    Contraception. 2021 Jun 9. pii: S0010-7824(21)00185.
    >> Share

  383. RODRIGUEZ MI, Kaufman M, Manibusan B, Anderson L, et al
    Medical contraindications to combined hormonal contraceptive use among women using methods prescribed by a pharmacist.
    Contraception. 2021 Jun 8. pii: S0010-7824(21)00187.
    >> Share

  384. LIN TK, Law R, Beaman J, Foster DG, et al
    The impact of the COVID-19 pandemic on economic security and pregnancy intentions among people at risk of pregnancy.
    Contraception. 2021;103:380-385.
    >> Share

  385. GILLIAM ML, Jensen JT, Eisenberg DL, Thomas MA, et al
    Relationship of parity and prior cesarean delivery to levonorgestrel 52 mg intrauterine system expulsion over 6 years.
    Contraception. 2021;103:444-449.
    >> Share

  386. RAYMOND EG, Anger HA, Chong E, Haskell S, et al
    "False positive" urine pregnancy test results after successful medication abortion.
    Contraception. 2021;103:400-403.
    >> Share

  387. FLYNN AN, Roe AH, Koelper N, McAllister A, et al
    Timing and efficacy of mifepristone pretreatment for medical management of early pregnancy loss.
    Contraception. 2021;103:404-407.
    >> Share

    May 2021
  388. RIVAS K, Schmuhl NB, Taboada M, Godecker A, et al
    Are Wisconsin resident physicians trained in immediate postpartum long acting reversible contraception?
    Contraception. 2021 May 31. pii: S0010-7824(21)00176.
    >> Share

  389. GOYAL V, Madison AM, Powers DA, Potter JE, et al
    Impact of Contraceptive Counseling on Texans Who Can and Cannot Receive No-Cost Post-Abortion Contraception.
    Contraception. 2021 May 30. pii: S0010-7824(21)00178.
    >> Share

  390. TI A, Soin K, Rahman T, Dam A, et al
    Contraceptive values and preferences of adolescents and young adults: a systematic review.
    Contraception. 2021 May 30. pii: S0010-7824(21)00179.
    >> Share

  391. KRAMER RD, Higgins JA, Burns ME, Stulberg DB, et al
    Expectations about Availability of Contraception and Abortion at a Hypothetical Catholic Hospital: Rural-Urban Disparities among Wisconsin Women.
    Contraception. 2021 May 28. pii: S0010-7824(21)00175.
    >> Share

  392. LASSAR M, Tao K, Bond T, Qadir S, et al
    Closing the contraceptive coverage gap: a multi-pronged approach to advancing reproductive equity in Illinois.
    Contraception. 2021 May 27. pii: S0010-7824(21)00157.
    >> Share

  393. KHIN YP, Nawa N, Fujiwara T, Surkan PJ, et al
    Access to contraceptive services among Myanmar women living in Japan: A qualitative study.
    Contraception. 2021 May 26. pii: S0010-7824(21)00155.
    >> Share

  394. SONG B, White VanGompel E, Wang C, Guzman S, et al
    Corrigendum to "Effects of Clinic-level Implementation of One Key Question(R) on Reproductive Health Counseling and Patient Satisfaction" [Contraception 103 (2021): 6-12].
    Contraception. 2021 May 25. pii: S0010-7824(21)00113.
    >> Share

  395. VEGA A, Choi YJ, Tschann M, Salcedo J, et al
    Over-the-Counter Access to Levonorgestrel Emergency Contraception in South Texas: Does Over-the-Counter Mean Ready to Buy?
    Contraception. 2021 May 21. pii: S0010-7824(21)00152.
    >> Share

  396. GIFFORD K, McDuffie MJ, Rashid H, Knight EK, et al
    Postpartum contraception method type and risk of a short inter-pregnancy interval in a state Medicaid population.
    Contraception. 2021 May 20. pii: S0010-7824(21)00153.
    >> Share

  397. CREININ MD, Westhoff CL, Bouchard C, Chen MJ, et al
    Estetrol-Drospirenone Combination Oral Contraceptive: North American Phase 3 Efficacy and Safety Results.
    Contraception. 2021 May 14. pii: S0010-7824(21)00149.
    >> Share

  398. KEOGH SC, Otupiri E, Castillo PW, Chiu DW, et al
    Hormonal contraceptive use in Ghana: the role of method attributes and side effects in method choice and continuation.
    Contraception. 2021 May 13. pii: S0010-7824(21)00151.
    >> Share

    April 2021
  399. COMFORT AB, Harper CC, Tsai AC, Moody J, et al
    Social and provider networks and women's contraceptive use: Evidence from Madagascar.
    Contraception. 2021 Apr 23. pii: S0010-7824(21)00129.
    >> Share

  400. ARIYO O, Khoury AJ, Smith MG, Leinaar E, et al
    From Training to Implementation: Improving Contraceptive Practices in South Carolina.
    Contraception. 2021 Apr 21. pii: S0010-7824(21)00132.
    >> Share

  401. DEV R, Kohler P, Begnel E, Achwoka D, et al
    Contraceptive counseling experiences among women attending HIV Care and Treatment Centers: a national survey in Kenya.
    Contraception. 2021 Apr 21. pii: S0010-7824(21)00127.
    >> Share

  402. STIFANI BM, Smith A, Avila K, Boos EW, et al
    Telemedicine for contraceptive counseling: patient experiences during the early phase of the Covid-19 pandemic in New York City.
    Contraception. 2021 Apr 13. pii: S0010-7824(21)00111.
    >> Share

  403. HUBER-KRUM S, Bornstein M, Garver S, Gipson J, et al
    Are rural Malawian women using their preferred contraceptive method and that of their male partners?
    Contraception. 2021 Apr 3. pii: S0010-7824(21)00100.
    >> Share

  404. BOUMA-JOHNSTON H, Ponsaran R, Arora KS
    Variation by state in Medicaid sterilization policies for physician reimbursement.
    Contraception. 2021;103:255-260.
    >> Share

    March 2021
  405. LIU JH, Plagianos M, Archer DF, Simon JA, et al
    Segesterone Acetate Serum Levels with a Regression Model of Continuous Use of the Segesterone Acetate/Ethinyl Estradiol Contraceptive Vaginal System.
    Contraception. 2021 Mar 27. pii: S0010-7824(21)00096.
    >> Share

  406. HADDAD LB, RamaRao S, Hazra A, Birungi H, et al
    Addressing contraceptive needs exacerbated by COVID-19: A call for increasing choice and access to self-managed methods.
    Contraception. 2021 Mar 26. pii: S0010-7824(21)00095.
    >> Share

  407. BONIFACE ER, Rodriguez MI, Heintzman J, Knipper S, et al
    Contraceptive provision in Oregon School-Based Health Centers: Method type trends and the role of Title X.
    Contraception. 2021 Mar 26. pii: S0010-7824(21)00092.
    >> Share

  408. BREWER M, Stevens L
    Use of Fertility Awareness-Based Methods of Contraception: Evidence from the National Survey of Family Growth, 2013-17.
    Contraception. 2021 Mar 21. pii: S0010-7824(21)00086.
    >> Share

  409. SKRACIC I, Lewin AB, Roy KM
    Evaluation of the Delaware Contraceptive Access Now (DelCAN) initiative: A qualitative analysis of site leaders' implementation recommendations.
    Contraception. 2021 Mar 21. pii: S0010-7824(21)00087.
    >> Share

  410. TEBB KP, Rodriguez F, Pollack LM, Adams S, et al
    Improving Contraceptive Use Among Latina Adolescents: A Cluster-Randomized Controlled Trial Evaluating an mHealth Application, Health-E You/Salud iTu.
    Contraception. 2021 Mar 17. pii: S0010-7824(21)00059.
    >> Share

  411. DUIJKERS I, Klipping C, Kinet V, Jost M, et al
    Effects of an oral contraceptive containing estetrol and drospirenone on ovarian function.
    Contraception. 2021 Mar 6. pii: S0010-7824(21)00058.
    >> Share

  412. GAFFIELD ME, Kiarie J
    Setting global standards: The paramount importance of considering contraceptive values and preferences of clients and providers.
    Contraception. 2021 Mar 5. pii: S0010-7824(18)30399.
    >> Share

  413. MCCARTHY M
    Contraceptive counseling following in-clinic pregnancy test among women not expecting pregnancy in the next two years: Disparities by service delivery setting and sociodemographic characteristics.
    Contraception. 2021 Mar 2. pii: S0010-7824(21)00055.
    >> Share

  414. DRAGOMAN MV, Grossman D, Nguyen MH, Habib N, et al
    Two prophylactic pain management regimens for medical abortion
    Contraception. 2021;103:163-170.
    >> Share

  415. NELSON AL, Kaunitz AM, Kroll R, Simon JA, et al
    Efficacy, safety, and tolerability of a levonorgestrel/ethinyl estradiol transdermal delivery system: Phase 3 clinical trial results.
    Contraception. 2021;103:137-143.
    >> Share

    February 2021
  416. THORNTON O, Daggett E, Zia L, Quian A, et al
    Counseling, Contraception, and Conception Rates in Patients Undergoing Bariatric Surgery: A Retrospective Review.
    Contraception. 2021 Feb 28. pii: S0010-7824(21)00053.
    >> Share

  417. STEINBERG JR, Marthey D, Xie L, Boudreaux M, et al
    Contraceptive method type and satisfaction, confidence in use, and switching intentions.
    Contraception. 2021 Feb 20. pii: S0010-7824(21)00051.
    >> Share

  418. LATACK KR, Yuen F, Wang C, Nguyen BT, et al
    Online community queries on hormonal male contraception: an analysis of the Reddit "Ask Me Anything" experience.
    Contraception. 2021 Feb 19. pii: S0010-7824(21)00050.
    >> Share

  419. CHAKRABORTY P, Gallo MF, Nawaz S, Smith M, et al
    Use of non-preferred contraceptive methods among women in Ohio.
    Contraception. 2021 Feb 16. pii: S0010-7824(21)00035.
    >> Share

  420. BERNDT VK, Bell AV
    Contextualizing Barriers to Long-Acting Reversible Contraception.
    Contraception. 2021 Feb 16. pii: S0010-7824(21)00036.
    >> Share

  421. BELL SO, Gemmill A
    Perceived likelihood of becoming pregnant and contraceptive use: Findings from population-based surveys in Cote d'Ivoire, Nigeria, and Rajasthan, India.
    Contraception. 2021 Feb 12. pii: S0010-7824(21)00031.
    >> Share

  422. MASTEY N, Matulich MC, Uhm S, Baker CC, et al
    U.S. referral center experience removing nonpalpable and difficult contraceptive implants with in-office ultrasonography: a case series.
    Contraception. 2021 Feb 8. pii: S0010-7824(21)00028.
    >> Share

  423. GIPSON JD, Bornstein M, Berger A, Rocca CH, et al
    Desire to Avoid Pregnancy and Contraceptive Use among Female Methadone Patients in Los Angeles.
    Contraception. 2021 Feb 7:9564. doi: 10.1016/j.contraception.2021.
    >> Share

  424. KIM C, Nguyen AT, Berry-Bibee E, Ermias Y, et al
    Systemic hormonal contraception initiation after abortion: a systematic review and meta-analysis.
    Contraception. 2021 Feb 3. pii: S0010-7824(21)00027.
    >> Share

  425. CANNON R, White K, Seifert B, Woodhams E, et al
    Exploring The Physician's Role in Contraceptive Counseling at the Time of Abortion in the US.
    Contraception. 2021 Feb 2. pii: S0010-7824(21)00024.
    >> Share

  426. GOLDMAN AR, Gerber SR
    Levonorgestrel intrauterine system (IUS) in a patient with uterine didelphys: A case report.
    Contraception. 2021;103:134-135.
    >> Share

    January 2021
  427. DUTTON C, Kim R, Janiak E
    Prevalence of contraindications to progestin-only contraceptive pills in a multi-institution patient database.
    Contraception. 2021 Jan 30. pii: S0010-7824(21)00020.
    >> Share

  428. CLELAND K, Marcantonio TL, Hunt ME, Jozkowski KN, et al
    "It prevents a fertilized egg from attaching...and causes a miscarriage of the baby": A qualitative assessment of how people understand the mechanism of action of emergency contraceptive pills.
    Contraception. 2021 Jan 25. pii: S0010-7824(21)00019.
    >> Share

  429. DEHLENDORF C, Fox E, Silverstein IA, Hoffman A, et al
    Development of the Patient-Centered Contraceptive Counseling scale (PCCC), a short form of the Interpersonal Quality of Family Planning Care scale.
    Contraception. 2021 Jan 25. pii: S0010-7824(21)00018.
    >> Share

  430. KRASHIN JW, Zapata LB, Morgan IA, Tepper NK, et al
    Required examinations and tests before initiating contraception: provider practices from a national cross-sectional survey.
    Contraception. 2021 Jan 14. pii: S0010-7824(21)00006.
    >> Share

  431. WILLIAMS BN, Jauk VC, Szychowski JM, Arbuckle JL, et al
    Adolescent Emergency Contraception Usage, Knowledge and Perception.
    Contraception. 2021 Jan 13. pii: S0010-7824(21)00005.
    >> Share

  432. KLIPPING C, Duijkers I, Mawet M, Maillard C, et al
    Endocrine and metabolic effects of an oral contraceptive containing estetrol and drospirenone.
    Contraception. 2021 Jan 8. pii: S0010-7824(21)00002.
    >> Share

  433. HYLTON-KONG T, Steiner MJ, Bailey A, Palazzi M, et al
    Debunking myths about contraceptive safety among women in Kingston, Jamaica: Pilot randomized controlled trial.
    Contraception. 2021 Jan 8. pii: S0010-7824(21)00003.
    >> Share

  434. EVANS ML, Qasba N, Shah Arora K
    COVID-19 highlights the policy barriers and complexities of postpartum sterilization.
    Contraception. 2021;103:3-5.
    >> Share

  435. CARR BR, Thomas MA, Gangestad A, Eisenberg DL, et al
    Conception rates in women desiring pregnancy after levonorgestrel 52 mg intrauterine system (Liletta(R)) discontinuation.
    Contraception. 2021;103:26-31.
    >> Share

  436. SEIDMAN D, Cavrois M, Hilton JF, Roan NR, et al
    Reproductive tract immune cells from pregnant women or those using depot medroxyprogesterone acetate show no excess susceptibility to HIV-1: Results of an ex vivo fusion assay.
    Contraception. 2021;103:44-47.
    >> Share

    December 2020
  437. CHE Y, Li Y, Gu X, Jiang L, et al
    Contraception, unintended pregnancy, and induced abortion within 24 months of delivery in China: a retrospective cohort study.
    Contraception. 2020 Dec 27. pii: S0010-7824(20)30467.
    >> Share

  438. EGARDT A, Algovik M, Kallner HK
    Adherence to Swedish national recommendations for long acting reversible contraceptive provision at the time of medical abortion.
    Contraception. 2020 Dec 26. pii: S0010-7824(20)30466.
    >> Share

  439. ELLISON J, Cole MB, Hanchate AD, Kazis L, et al
    Non-Indicated Pelvic Examinations During Contraceptive Encounters: Prevalence and Provider Variations.
    Contraception. 2020 Dec 26. pii: S0010-7824(20)30464.
    >> Share

  440. BESHAR I, So J, Chelvakumar M, Cahill EP, et al
    Socioeconomic Differences Persist in Use of Permanent versus Long-Acting Reversible Contraception: An Analysis of the National Survey for Family Growth, 2006-2010 versus 2015-2017.
    Contraception. 2020 Dec 23. pii: S0010-7824(20)30461.
    >> Share

  441. NAMKUNG EH, Valentine A, Warner L, Mitra M, et al
    Contraceptive Use at First Sexual Intercourse among Adolescent and Young Adult Women with Disabilities: The Role of Formal Sex Education.
    Contraception. 2020 Dec 23. pii: S0010-7824(20)30460.
    >> Share

  442. SUNAGA T, Cicali B, Schmidt S, Brown J, et al
    Comparison of contraceptive failures associated with CYP3A4-inducing drug-drug interactions by route of hormonal contraceptive in an adverse event reporting system.
    Contraception. 2020 Dec 17. pii: S0010-7824(20)30439.
    >> Share

  443. HARRIS S, Kaneshiro B, Ahn HJ, Saito-Tom L, et al
    Timing of Insertion Affects Expulsion in Patients using the Levonorgestrel 52 mg Intrauterine System for Non-Contraceptive Indications.
    Contraception. 2020 Dec 5. pii: S0010-7824(20)30435.
    >> Share


  444. Corrigendum to "Dose-finding study of a 90-day contraceptive vaginal ring releasing estradiol and segesterone acetate" [Contraception 102(3) (2020) 168-173].
    Contraception. 2020;102:433.
    >> Share

  445. KATZ M, Newmark RL, Aronstam A, O'Grady N, et al
    An implementation project to expand access to self-administered depot medroxyprogesterone acetate (DMPA).
    Contraception. 2020;102:392-395.
    >> Share

    November 2020
  446. KIM CS, Lunde B, MacIsaac L, Arden M, et al
    Provision of Contraceptive Implants in School-Based Health Centers: A Cost-Effectiveness Analysis.
    Contraception. 2020 Nov 19. pii: S0010-7824(20)30420.
    >> Share

  447. STIFANI BM, Avila K, Levi EE
    Telemedicine for contraceptive counseling: an exploratory survey of US family planning providers following rapid adoption of services during the COVID-19 pandemic.
    Contraception. 2020 Nov 16. pii: S0010-7824(20)30416.
    >> Share

  448. SUMARSONO A, Segar MW, PharmD LX, Atem F, et al
    Medicaid Expansion and Provision of Prescription Contraception to Medicaid Beneficiaries.
    Contraception. 2020 Nov 16. pii: S0010-7824(20)30415.
    >> Share

  449. SHETH AN, Angert CD, Haddad LB, Mehta CC, et al
    Contraception methods used among women with HIV starting antiretroviral therapy in a large United States clinical trial, 2009-2011.
    Contraception. 2020 Nov 12. pii: S0010-7824(20)30414.
    >> Share

  450. CHARLTON BM, Reynolds CA, Janiak E, DiVasta AD, et al
    Sexual orientation-related differences in contraceptive use: a brief report based on a cohort of adolescent and young women.
    Contraception. 2020 Nov 12. pii: S0010-7824(20)30412.
    >> Share

  451. STRANSKY OM, Wolgemuth T, Kazmerski T, Chodoff A, et al
    Contraception Decision-Making and Care Among Reproductive-Aged Women with Autoimmune Diseases.
    Contraception. 2020 Nov 9. pii: S0010-7824(20)30406.
    >> Share

  452. HUYSMAN BC, Paul R, Rivera AN, Tal E, et al
    Patient and counselor satisfaction with structured contraceptive counseling by health center staff in federally qualified health centers.
    Contraception. 2020 Nov 5. pii: S0010-7824(20)30405.
    >> Share

    October 2020
  453. ECKHAUS LM, Ti AJ, Curtis KM, Stewart-Lynch AL, et al
    Patient and pharmacist perspectives on pharmacist-prescribed contraception: a systematic review.
    Contraception. 2020 Oct 29. pii: S0010-7824(20)30382.
    >> Share

  454. BUASAWAT P, Manonai J, Ngamjanyaporn P
    Perception of Contraceptive Counseling and Contraceptive Use among Systemic Lupus Erythematosus Patients.
    Contraception. 2020 Oct 29. pii: S0010-7824(20)30387.
    >> Share

  455. UHM S, Chen MJ, Cutler ED, Creinin MD, et al
    Twelve-month prescribing of contraceptive pill, patch, and ring before and after a standardized electronic medical record order change.
    Contraception. 2020 Oct 21. pii: S0010-7824(20)30381.
    >> Share

  456. HAVERINEN A, Kangasniemi M, Luiro K, Piltonen T, et al
    Ethinyl Estradiol vs Estradiol Valerate in Combined Oral Contraceptives - Effect on Glucose Tolerance: A Randomized, Controlled Clinical Trial.
    Contraception. 2020 Oct 21. pii: S0010-7824(20)30384.
    >> Share

  457. CHIRUVELLA M, Schaffir J, Benedict JA, Tedesco C, et al
    Is provision of contraception at discharge following delivery associated with postpartum visit attendance?
    Contraception. 2020 Oct 21. pii: S0010-7824(20)30385.
    >> Share

  458. EHN B, Anderberg P, Sanmartin Berglund J, Lilje S, et al
    The process of opting for female permanent contraception: A qualitative study of women's experiences in Sweden.
    Contraception. 2020 Oct 14. pii: S0010-7824(20)30359.
    >> Share

  459. ARCARA J, Arteaga S, Burny I, Manchikanti Gomez A, et al
    Changes in Expectation of Relationship Permanence, Pregnancy Acceptability and Desire, and Contraceptive Use Over Time Among Young Latino/a Women and Men: An Exploratory Analysis.
    Contraception. 2020 Oct 7. pii: S0010-7824(20)30356.
    >> Share

    September 2020
  460. PETERSON SF, Blumenthal PD
    Intra-abdominal placement of postplacental levonorgestrel intrauterine system: A case report.
    Contraception. 2020;102:224.
    >> Share

  461. CARUGNO J
    Post-placental intra-abdominal placement of levonorgestrel 52mg intrauterine system: A case report.
    Contraception. 2020;102:222-223.
    >> Share

    April 2020
  462. RODEN RC, Noritz G, McKnight ER, Bonny AE, et al
    An exploratory study of depot-medroxyprogesterone acetate and bone mineral density in adolescent and young adult women with cerebral palsy.
    Contraception. 2020;101:273-275.
    >> Share

  463. STULBERG DB, Datta A, White VanGompel E, Schueler K, et al
    One Key Question(R) and the Desire to Avoid Pregnancy Scale: A comparison of two approaches to asking about pregnancy preferences.
    Contraception. 2020;101:231-236.
    >> Share

  464. LAROCHE KJ, Wynn LL, Foster AM
    "We've got rights and yet we don't have access": Exploring patient experiences accessing medication abortion in Australia.
    Contraception. 2020;101:256-260.
    >> Share

  465. DENNIS A, Manski R, O'Donnell J
    Assessing research impact: A framework and an evaluation of the Society of Family Planning Research Fund's grantmaking (2007-2017).
    Contraception. 2020;101:213-219.
    >> Share

    March 2020
  466. LAPORTE M, Marangoni M Jr, Surita F, Juliato CT, et al
    Postplacental placement of intrauterine devices: A randomized clinical trial.
    Contraception. 2020;101:153-158.
    >> Share

  467. SRINIVASULU S, Shah SD, Schechter CB, Prine L, et al
    Effectiveness of clinical decision support to enhance delivery of family planning services in primary care settings.
    Contraception. 2020;101:199-204.
    >> Share

    February 2020
  468. MANZE MG, Calixte C, Romero DR, Roberts L, et al
    Physician perspectives on routine pregnancy intention screening and counseling in primary care.
    Contraception. 2020;101:91-96.
    >> Share

  469. RICHTER WH, Koytchev R, Kirkov V, Merki G, et al
    Comparative pharmacokinetic estimates of drospirenone alone and in combination with ethinyl estradiol after single and repeated oral administration in healthy females.
    Contraception. 2020;101:137-143.
    >> Share

    January 2020
  470. KAPP N, Methazia J, Eckersberger E, Griffin R, et al
    Label comprehension of a combined mifepristone and misoprostol product for medical abortion: A pilot study in South Africa.
    Contraception. 2020;101:46-52.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016